Page last updated: 2024-11-06

thyroxine and Carcinoma, Anaplastic

thyroxine has been researched along with Carcinoma, Anaplastic in 181 studies

Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.

Research Excerpts

ExcerptRelevanceReference
"To evaluate if a supervised exercise training program improves the quality of life (QoL) of differentiated thyroid carcinoma (DTC) patients on TSH-suppressive therapy with levothyroxine (L-T4)."9.19Exercise is associated with better quality of life in patients on TSH-suppressive therapy with levothyroxine for differentiated thyroid carcinoma. ( Chachamovitz, DS; Rocque, Mde L; Santos, ML; Teixeira, Pde F; Vaisman, M; Vigário, Pdos S, 2014)
"We measured serum thyroxine (T4), free T4, 3,5,3-triiodothyronine (T3), free T3, reverse T3 (rT3), and TSH concentrations at baseline and after 26 wk in 21 patients with progressive nonmedullary thyroid carcinoma treated with sorafenib."9.14Sorafenib-induced hypothyroidism is associated with increased type 3 deiodination. ( Abdulrahman, RM; Corssmit, EP; Gelderblom, H; Hoftijzer, H; Hovens, GC; Kapiteijn, E; Pereira, AM; Reiners, C; Romijn, JA; Smit, JW; Verburg, E; Verloop, H; Visser, TJ, 2010)
" The aim of the present study was to estimate the influence of L-thyroxine (L-T4) administration on poor-platelet plasma (P-PP) VEGF concentrations in patients with induced short-term hypothyroidism, monitored for differentiated thyroid carcinoma."9.12Influence of L-thyroxine administration on poor-platelet plasma VEGF concentrations in patients with induced short-term hypothyroidism, monitored for thyroid carcinoma. ( Adamczewski, Z; Brzeziński, J; Dedecjus, M; Kołomecki, K; Lewiński, A; Tazbir, J, 2007)
"The effect of subclinical hyperthyroidism on bone mineral density is controversial and could be significant in patients with differentiated thyroid carcinoma who receive suppressive doses of levothyroxine (LT4)."9.11Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma. ( Alonso, N; Granada, ML; Holgado, S; Reverter, JL; Salinas, I; Sanmartí, A, 2005)
"The patient developed Graves' disease after lenvatinib treatment for radioactive iodine refracted thyroid follicular carcinoma."8.12Hyperthyroidism due to thyrotropin receptor antibody stimulation of metastatic thyroid carcinoma during lenvatinib treatment: a case report. ( Iwasaki, H; Kadoya, M; Matsui, A; Murayama, D; Toda, S, 2022)
"Studies on the effect of exogenous subclinical thyrotoxicosis on bone mineral density (BMD) in male patients treated with suppressive doses of levothyroxine for differentiated thyroid carcinoma (DTC) are not conclusive."7.76Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine treatment for differentiated thyroid carcinoma. ( Aguilera, E; Colomé, E; Holgado, S; Mateo, L; Reverter, JL; Sanmartí, A; Soldevila, B, 2010)
"The aim of our study was to evaluate the acute effect of the recombinant human TSH (rhTSH)-induced TSH surge on serum leptin levels in thyroidectomized patients undergoing levothyroxine (L-T4) suppressive therapy for differentiated thyroid carcinoma (DTC)."7.74Absence of thyrotropin-induced increase in leptin levels in patients with history of differentiated thyroid carcinoma undergoing recombinant human thyrotropin testing. ( Andraghetti, G; Briatore, L; Cavallero, D; Cecoli, F; Ghiara, C; Giusti, M; Minuto, F; Mussap, M, 2008)
"Patients with differentiated thyroid carcinoma (DTC) must receive suppressive levothyroxine (LT(4)) therapy for the rest of their lives."7.72Bone metabolism in patients with differentiated thyroid carcinoma receiving suppressive levothyroxine treatment. ( Gallowitsch, HJ; Jauk, B; Jost, R; Kresnik, E; Leb, G; Lind, P; Mikosch, P; Obermayer-Pietsch, B, 2003)
"Life-time L-thyroxine therapy is obligatory in patients treated for differentiated thyroid carcinoma (DTC) in order to suppress serum TSH."7.71[L-thyroxine therapy in differentiated thyroid carcinoma: criteria for evaluation of TSH suppression]. ( Czernik, E; Gubała, E; Jarzab, B; Jurecka-Tuleja, B; Kowalczyk, P; Roskosz, J, 2001)
"To determine bone mineral density in patients with differentiated thyroid carcinoma receiving thyroxine replacement therapy in suppressive doses, we studied 65 patients (47 women and 18 men; age 25-83 years, mean+/-SD 52."7.69Bone mineral density in patients receiving suppressive doses of thyroxine for differentiated thyroid carcinoma. ( Görres, G; Götze, M; Kaim, A; Müller-Brand, J; Otte, A, 1996)
"A comparative analysis of triiodothyronine (T3) and thyroxine (T4) distribution in organs and tissues of tumour-bearing and intact mice conducted wih 125J labelled T3 and T4 has shown considerable differences in the accumulation character of these hormones in mice with Lewis carcinoma and in intact animals in the liver, kidneys, lungs, adrenal glands, lymphatic nodes."7.67[Distribution kinetics and metabolism of triiodothyronine and thyroxine in the organs and tissues of mice with transplanted Lewis carcinoma]. ( Dedenkov, AN; Norets, TA; Petrova, GA; Smoryzanova, OA; Vereshchagina, GV, 1985)
"Forty patients with thyroid cancer submitted to thyroidectomy, who received 3."6.82Radioiodine-induced oxidative stress in patients with differentiated thyroid carcinoma and effect of supplementation with vitamins C and E and selenium (antioxidants). ( Batista, KC; Calsolari, MR; Rosário, PW, 2016)
"To evaluate if a supervised exercise training program improves the quality of life (QoL) of differentiated thyroid carcinoma (DTC) patients on TSH-suppressive therapy with levothyroxine (L-T4)."5.19Exercise is associated with better quality of life in patients on TSH-suppressive therapy with levothyroxine for differentiated thyroid carcinoma. ( Chachamovitz, DS; Rocque, Mde L; Santos, ML; Teixeira, Pde F; Vaisman, M; Vigário, Pdos S, 2014)
"We measured serum thyroxine (T4), free T4, 3,5,3-triiodothyronine (T3), free T3, reverse T3 (rT3), and TSH concentrations at baseline and after 26 wk in 21 patients with progressive nonmedullary thyroid carcinoma treated with sorafenib."5.14Sorafenib-induced hypothyroidism is associated with increased type 3 deiodination. ( Abdulrahman, RM; Corssmit, EP; Gelderblom, H; Hoftijzer, H; Hovens, GC; Kapiteijn, E; Pereira, AM; Reiners, C; Romijn, JA; Smit, JW; Verburg, E; Verloop, H; Visser, TJ, 2010)
"Twenty-five subjects with a history of differentiated thyroid carcinoma with > 10 years TSH-suppressive therapy with l-thyroxine completed the study."5.12Glucose tolerance and lipid profile in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomised controlled trial. ( Corssmit, EP; Eustatia-Rutten, CF; Frölich, M; Heemstra, KA; Heijboer, AC; Romijn, JA; Smit, JW, 2006)
" The aim of the present study was to estimate the influence of L-thyroxine (L-T4) administration on poor-platelet plasma (P-PP) VEGF concentrations in patients with induced short-term hypothyroidism, monitored for differentiated thyroid carcinoma."5.12Influence of L-thyroxine administration on poor-platelet plasma VEGF concentrations in patients with induced short-term hypothyroidism, monitored for thyroid carcinoma. ( Adamczewski, Z; Brzeziński, J; Dedecjus, M; Kołomecki, K; Lewiński, A; Tazbir, J, 2007)
"The effect of subclinical hyperthyroidism on bone mineral density is controversial and could be significant in patients with differentiated thyroid carcinoma who receive suppressive doses of levothyroxine (LT4)."5.11Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma. ( Alonso, N; Granada, ML; Holgado, S; Reverter, JL; Salinas, I; Sanmartí, A, 2005)
" Recombinant TSH is comparable to hypothyroidism in the generation of Tg and in the execution of iodine-131 whole-body scanning, with the advantage of sparing patients from the symptoms of hypothyroidism and from impaired quality of life induced by levothyroxine withdrawal, in addition to a reduced exposure to elevated TSH and shorter absence from work, with recombinant TSH being the preparation indicated for the diagnosis of metastases in both low risk (Tg after recombinant TSH) and moderate or high risk patients (Tg and iodine-131 scanning after recombinant TSH)."4.82[Recombinant TSH in ablative therapy and follow-up of patients with differentiated thyroid carcinoma]. ( Barroso, AL; Fagundes, TA; Padrão, EL; Purisch, S; Rezende, LL; Rosário, PW, 2005)
"The patient developed Graves' disease after lenvatinib treatment for radioactive iodine refracted thyroid follicular carcinoma."4.12Hyperthyroidism due to thyrotropin receptor antibody stimulation of metastatic thyroid carcinoma during lenvatinib treatment: a case report. ( Iwasaki, H; Kadoya, M; Matsui, A; Murayama, D; Toda, S, 2022)
"A prospective cohort study was conducted, in which, patients with differentiated thyroid carcinoma and benign thyroid nodules were given oral L-T4 therapy after surgery, after meeting the criteria of TSH suppression therapy and thyroxine replacement therapy, respectively, the patients were continually given L-T4 therapy for 6 and 12 months, and then, the neuropsychological test was performed."3.91Naming difficulties after thyroid stimulating hormone suppression therapy in patients with differentiated thyroid carcinoma: a prospective cohort study. ( Ai, JW; Bai, Y; Bao, W; Jin, S; Liu, Y; Yang, YT; Yong, H, 2019)
" These assessments were analyzed against perioperative measurements to determine if any of these preoperative values were predictive of postoperative hypothyroidism and the need for postoperative levothyroxine treatment."3.81Prediction of thyroid hormone supplementation after thyroid lobectomy. ( Ahn, SH; Jeong, WJ; Lee, DY; Seok, J, 2015)
" We report a patient with papillary thyroid carcinoma who were under treatment with levothyroxine and experienced an elevated TSH level by ingestion of Carum carvi."3.81Carum induced hypothyroidism: an interesting observation and an experiment. ( Ayati, N; Naghibi, SM; Ramezani, M; Zakavi, SR, 2015)
"Thyroxine (T4) requirement after total thyroidectomy for differentiated thyroid carcinoma (DTC) is a debated issue."3.81Individually-tailored thyroxine requirement in the same patients before and after thyroidectomy: a longitudinal study. ( Brusca, N; Cellini, M; Centanni, M; Del Duca, SC; Frattaroli, FM; Gargano, L; Gatto, I; Santaguida, MG; Verga Falzacappa, C; Virili, C, 2015)
"Thyroid function was measured by means of thyroid stimulating hormone (TSH), free thyroxine (FT4) and free triiodthyronine (FT3) in 43 patients who had nonthyroid head-neck carcinomas treated by radiotherapy or radiotherapy in combination with other modalities."3.80Hypothyroidism after radiotherapy of head and neck cancer. ( Bernát, L; Hrušák, D, 2014)
"A cross-sectional study was carried out with 29 patients on TSH-suppressive therapy with levothyroxine for thyroid carcinoma and 35 euthyroid subjects."3.77Impaired functional and hemodynamic response to graded exercise testing and its recovery in patients with subclinical hyperthyroidism. ( Chachamovitz, DS; Oliveira, FP; Santos, MA; Teixeira, Pde F; Vaisman, M; Vigário, Pdos S, 2011)
"Studies on the effect of exogenous subclinical thyrotoxicosis on bone mineral density (BMD) in male patients treated with suppressive doses of levothyroxine for differentiated thyroid carcinoma (DTC) are not conclusive."3.76Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine treatment for differentiated thyroid carcinoma. ( Aguilera, E; Colomé, E; Holgado, S; Mateo, L; Reverter, JL; Sanmartí, A; Soldevila, B, 2010)
"We studied 11 patients, previously treated with thyroidectomy for differentiated thyroid carcinoma, during hypothyroidism caused by cessation of thyroxine substitution for 4 weeks and during thyroxine replacement therapy, and 21 matched healthy controls."3.76Short-term overt hypothyroidism induces sympathovagal imbalance in thyroidectomized differentiated thyroid carcinoma patients. ( Burggraaf, J; Corssmit, EP; Heemstra, KA; Romijn, JA; Smit, JW; van der Klaauw, AA, 2010)
" The aim of this study was to evaluate the effect of antibone resorptive agents, in particular alendronate (ALN) on BMD in postmenopausal osteoporotic women with thyroid carcinoma who were receiving long-term thyrotropin (TSH)-suppressive therapy with thyroxine."3.75Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate. ( Assante, R; Fonderico, F; Lupoli, G; Lupoli, GA; Marciello, F; Martinelli, A; Panico, A, 2009)
" Here we report an unusual case with radiation-induced hypothyroidism who had undergone hemithyroidectomy for adenomatous goiter 8 years before the radiotherapy for nasopharyngeal cancer and subclinical hyperthyroidism due to Graves' disease developed during thyroxine replacement therapy."3.74Development of subclinical hyperthyroidism due to Graves' disease in a hypothyroid woman who had undergone hemithyroidectomy for adenomatous goiter and radiotherapy for nasopharyngeal cancer. ( Hoshikawa, S; Ito, S; Mori, K; Nakagawa, Y; Ozaki, H; Yoshida, K, 2007)
"The aim of our study was to evaluate the acute effect of the recombinant human TSH (rhTSH)-induced TSH surge on serum leptin levels in thyroidectomized patients undergoing levothyroxine (L-T4) suppressive therapy for differentiated thyroid carcinoma (DTC)."3.74Absence of thyrotropin-induced increase in leptin levels in patients with history of differentiated thyroid carcinoma undergoing recombinant human thyrotropin testing. ( Andraghetti, G; Briatore, L; Cavallero, D; Cecoli, F; Ghiara, C; Giusti, M; Minuto, F; Mussap, M, 2008)
"Thyroxine (T4) withdrawal or recombinant TSH is used for the stimulation of thyroglobulin (Tg), whole-body scanning (WBS) and iodine-131 treatment in patients with thyroid carcinoma."3.73Managing thyroid cancer without thyroxine withdrawal. ( Barroso, AL; Cardoso, LD; Guimarães, VC; Lauria, MW; Padrão, EL; Purisch, S; Rezende, LL; Rosário, PW; Vasconcelos, FP, 2006)
" Leukocytosis, hypoalbuminemia and hypothyroxinemia indicated poor prognosis."3.73Prognostic factors of anaplastic thyroid carcinoma. ( Jiang, JY; Tseng, FY, 2006)
"To compare bone mineral density (BMD) of lumbar spines (LS) and femoral neck (FN) by Dual energy X-ray absorptiometry (DEXA) in premenopausal well-differentiated thyroid carcinoma women S/P total or near total thyroidectomy with a control group and the effect of Levothyroxine (LT4) to BMD between short term and long term treatment."3.73The comparative study of bone mineral density between premenopausal women receiving long term suppressive doses of levothyroxine for well-differentiated thyroid cancer with healthy premenopausal women. ( Panichkul, S; Rajchadara, S; Sajjinanont, T; Sriassawaamorn, N, 2005)
"Patients with differentiated thyroid carcinoma (DTC) are commonly treated long-term with thyrotropin (TSH)- suppressive thyroxine replacement therapy resolving in a state of subclinical hyperthyroidism."3.73The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma. ( Hamdy, NA; Heemstra, KA; Romijn, JA; Smit, JW, 2006)
"Patients with differentiated thyroid carcinoma (DTC) must receive suppressive levothyroxine (LT(4)) therapy for the rest of their lives."3.72Bone metabolism in patients with differentiated thyroid carcinoma receiving suppressive levothyroxine treatment. ( Gallowitsch, HJ; Jauk, B; Jost, R; Kresnik, E; Leb, G; Lind, P; Mikosch, P; Obermayer-Pietsch, B, 2003)
"Patients with differentiated thyroid carcinoma (DTC) receive a life time l-thyroxine therapy in suppressive doses and may exhibit signs of cardiac hypertrophy."3.71[Effects of L-thyroxine suppressive therapy on cardiac mass in patients with differentiated thyroid cancer]. ( Czernik, E; Gubała, E; Jarzab, B; Kowalczyk, P; Matuszewska, G; Nowak, J; Roskosz, J; Sielańczyk, A, 2001)
"Life-time L-thyroxine therapy is obligatory in patients treated for differentiated thyroid carcinoma (DTC) in order to suppress serum TSH."3.71[L-thyroxine therapy in differentiated thyroid carcinoma: criteria for evaluation of TSH suppression]. ( Czernik, E; Gubała, E; Jarzab, B; Jurecka-Tuleja, B; Kowalczyk, P; Roskosz, J, 2001)
"To examine whether suppressive doses of thyroxine have any adverse effects on bone, we evaluated various bone metabolic markers (lectin-precipitated alkaline phosphatase, osteocalcin, carboxyl-terminal region of type I collagen propeptide, tartrate-resistant alkaline phosphatase, and urinary excretion of hydroxyproline and pyridinium crosslinks), incidence of vertebral deformity, total body and regional (lumbar spine and radius) bone mineral densities (BMDs), and rates of bone loss in 24 late postmenopausal (more than 5 years after menopause) women who were treated with levothyroxine (L-T4) after total thyroidectomy for differentiated carcinoma."3.69Suppressive doses of thyroxine do not accelerate age-related bone loss in late postmenopausal women. ( Ashizawa, K; Fujiyama, K; Ito, M; Kimura, H; Kiriyama, T; Nagataki, S; Nagayama, Y; Tsuruta, M; Villadolid, MC; Yokoyama, N, 1995)
" In papillary carcinoma thyroxine administration (P < 0."3.69Thyroid cancer: a multivariate analysis on influence of treatment on long-term survival. ( Staunton, MD, 1994)
"To determine bone mineral density in patients with differentiated thyroid carcinoma receiving thyroxine replacement therapy in suppressive doses, we studied 65 patients (47 women and 18 men; age 25-83 years, mean+/-SD 52."3.69Bone mineral density in patients receiving suppressive doses of thyroxine for differentiated thyroid carcinoma. ( Görres, G; Götze, M; Kaim, A; Müller-Brand, J; Otte, A, 1996)
"3 years) after thyroidectomy with or without subsequent radioablation for differentiated thyroid carcinoma, before and after the interruption of suppressive thyroxine (T4) replacement therapy for 5 weeks."3.67How to deal with undetectable and low measurable serum thyroglobulin levels in the follow-up of patients with differentiated thyroid carcinoma? ( Lamberg, BA; Välimäki, M, 1985)
"03 microU/ml, in 183 patients operated upon for differentiated thyroid carcinoma and followed up while under treatment with L-thyroxine."3.67[Postoperative surveillance of differentiated thyroid epithelioma. Contribution of the ultrasensitive determination of TSH]. ( Comoy, E; De Vathaire, F; Fragu, P; Parmentier, C; Schlumberger, M; Wu-Ahouju, G, 1987)
"A comparative analysis of triiodothyronine (T3) and thyroxine (T4) distribution in organs and tissues of tumour-bearing and intact mice conducted wih 125J labelled T3 and T4 has shown considerable differences in the accumulation character of these hormones in mice with Lewis carcinoma and in intact animals in the liver, kidneys, lungs, adrenal glands, lymphatic nodes."3.67[Distribution kinetics and metabolism of triiodothyronine and thyroxine in the organs and tissues of mice with transplanted Lewis carcinoma]. ( Dedenkov, AN; Norets, TA; Petrova, GA; Smoryzanova, OA; Vereshchagina, GV, 1985)
" Homogenates of human thyroid follicular adenoma and carcinomas were incubated with [125I]T4 and dithiothreitol (DTT) at 37 C for 60 min under N2 gas."3.66Triiodothyronine generation from thyroxine in human thyroid: enhanced conversion in Graves' thyroid tissue. ( Imura, H; Inada, M; Ishii, H; Mashio, Y; Naito, K; Nishikawa, M; Tanaka, K, 1981)
"The study was performed to evaluate the influence of thyroxine substitution therapy and the presence of thyroglobulin antibodies (TgAb) on the usefulness of serum thyroglobulin (Tg) measurements in the follow-up of patients treated for well differentiated thyroid carcinoma."3.66Influence of thyroid substitution therapy and thyroid autoantibodies on the value of serum thyroglobulin in recurring thyroid cancer. ( Feldt-Rasmussen, U; Hansen, HS; Holten, I, 1983)
"Forty patients with thyroid cancer submitted to thyroidectomy, who received 3."2.82Radioiodine-induced oxidative stress in patients with differentiated thyroid carcinoma and effect of supplementation with vitamins C and E and selenium (antioxidants). ( Batista, KC; Calsolari, MR; Rosário, PW, 2016)
"UGT1A haplotypes associate with T4 dosage in DTC patients, but the effect accounts for only 2% of the total variability and recommendation of pre-emptive UGT1A genotyping is not warranted."2.79Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer. ( Barros Filho, Mde C; Bulzico, DA; Kowalski, LP; Meirelles, RM; Neves, RR; Paula, DP; Pessoa, CN; Santoro, AB; Struchine, CJ; Suarez-Kurtz, G; Vargens, DD, 2014)
" However, careful titration of T4 dosage to maintain biochemical euthyroidism is a better way to avoid the adverse effect of T4 on bone."2.68Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin. ( Kung, AW; Yeung, SS, 1996)
"We report a rare case of concurrent RT, acute suppurative thyroiditis, and micropapillary carcinoma in a 48-year-old patient."2.49Case of concurrent Riedel's thyroiditis, acute suppurative thyroiditis, and micropapillary carcinoma. ( Chu, YC; Hong, JT; Hong, SB; Kim, SH; Kim, YS; Lee, JH; Nam, M, 2013)
"Thyroid cancer is the most common endocrine malignancy, although representing fewer than 1% of all human tumors."2.48Approach to and treatment of differentiated thyroid carcinoma. ( Castagna, MG; Pacini, F, 2012)
"Its occurrence with differentiated thyroid cancer, particularly papillary thyroid carcinoma (PTC), even if rare, has been described."2.47Papillary thyroid carcinoma in Peutz-Jeghers syndrome. ( Bagnulo, R; Giagulli, VA; Guastamacchia, E; Lastella, P; Licchelli, B; Renzulli, G; Resta, F; Resta, N; Sabbà, C; Stella, A; Tafaro, E; Triggiani, V, 2011)
"Primary therapy of thyroid cancer is an adequate surgery: total thyreoidectomy and, if necessary, lymph node dissection or limited surgery in selected cases."2.47[Differentiated thyroid cancer -- 2009]. ( Konrády, A, 2011)
"Although thyroid nodules are common and cause concern about possible malignancy, relatively few are thyroid cancers, and relatively few thyroid cancers are lethal."2.39Thyroid nodules and the detection of thyroid cancer. ( Haber, RS, 1996)
"Thyroid cysts are rare in cats and poorly documented."1.46Thyroid Cysts in Cats: A Retrospective Study of 40 Cases. ( Broome, MR; Miller, ML; Norsworthy, GD; Peterson, ME; Randolph, JF; Rishniw, M, 2017)
"Hypothyroidism is an undesirable sequela of both surgery and radiotherapy, the two most commonly used modalities of treatment."1.43Postoperative hypofunctioning of the thyroid gland after total laryngectomy. ( Biswas, KD; Dutta, S; Ghatak, S; Haldar, D; Sen, I; Sinha, R, 2016)
" This model uses the patient's body surface area (BSA) along with the fractional whole-body retention (WBR) at 48 hours following oral administration of a diagnostic dosage of (131)I."1.42Validation of a Simple Thyroid Cancer Dosimetry Model Based on the Fractional Whole-Body Retention at 48 Hours Post-Administration of (131)I. ( Atkins, F; Burman, K; Moreau, S; Van Nostrand, D; Wartofsky, L, 2015)
"The cell lines may be useful for thyroid cancer research."1.40Functional analysis of three novel cell lines derived from human papillary thyroid carcinomas with three different clinical courses. ( Hashimoto, H; Hirose, T; Ishikawa, M; Ito, T; Minami, S; Shibuya, K; Tachibana, T; Toyomura, J; Tsuboi, K; Yoshino, G, 2014)
"In patients with differentiated thyroid cancer (DTC), the stimulated serum thyroglobulin (Tg) level at radioiodine ablation is a known predictive factor of persistent disease."1.40Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden. ( Bardet, S; Blanchard, D; Ciappuccini, R; de Raucourt, D; Hardouin, J; Heutte, N; Quak, E; Rame, JP; Vaur, D, 2014)
"Although functioning thyroid cancer metastases have been reported, they have almost never been reported for the clear cell variant of papillary thyroid carcinoma (PTC)."1.38Euthyroid status after total thyroidectomy due to functioning lung metastases from a clear cell variant of papillary thyroid carcinoma. ( Cho, BY; Chung, YJ; Lee, JI; Park, SJ; Ryu, HS, 2012)
"The best treatment option for recurrent papillary thyroid carcinoma (PTC) is reoperation when the recurrent lesion is locoregional."1.38Serum thyroglobulin level measured after thyroxine withdrawal is useful to predict further recurrence in whole body scan-negative papillary thyroid cancer patients after reoperation. ( Ahn, HY; Cho, BY; Choi, HS; Kim, KW; Kim, TH; Lee, EK; Lee, YJ; Lim, JA; Park, DJ; Park, YJ; Yi, KH, 2012)
"The likelihood of papillary thyroid carcinoma is reduced when TSH is lower, as in thyroid autonomy, and increased when TSH is higher, as in thyroid autoimmunity."1.38Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease. ( Fiore, E; Vitti, P, 2012)
"This study evaluated the potential effects and dose-response relationship of LT(4) therapy on bone mineral density (BMD) as well as bone and muscle strength."1.38Effects of levothyroxine on bone mineral density, muscle force, and bone turnover markers: a cohort study. ( Reiners, C; Schneider, M; Schneider, P; Schneider, R, 2012)
"Following thyroidectomy, a patient with papillary thyroid carcinoma was found to have widespread radioiodine-avid metastatic lesions and was treated with I-131."1.37Radioiodine dilution due to levothyroxine when using recombinant human thyroid-stimulating hormone: case report and discussion. ( Klein, HA, 2011)
"In Patient 1, histology showed a papillary thyroid carcinoma pT2."1.37Differentiated thyroid cancer in two patients with resistance to thyroid hormone. ( Capoluongo, E; Concolino, P; Corsello, SM; Locantore, P; Lovicu, RM; Paragliola, RM; Pontecorvi, A; Senes, P, 2011)
"Thyrotropin (TSH) changes in extreme primary hypothyroidism include increased secretion, slowed degradation, and diminished or absent TSH circadian rhythms."1.36TSH regulation dynamics in central and extreme primary hypothyroidism. ( DiStefano, JJ; Eisenberg, MC; Marsili, A; Pinchera, A; Santini, F, 2010)
"Patients with differentiated thyroid cancer (DTC) usually have a good prognosis but may experience a decline in quality of life (QOL)."1.35Illness perception in patients with differentiated epithelial cell thyroid cancer. ( Benbassat, C; Ginat, M; Grozinski-Glasberg, S; Hirsch, D; Levy, S; Mansiterski, Y; Reicher-Atir, R; Shimon, I; Shraga-Slutzky, I; Singer, J; Tsvetov, G; Weinstein, R, 2009)
"Four of five patients with lung metastases upon CT had a positive RxWBS."1.34Management of low-risk patients with thyroid carcinoma and detectable thyroglobulin on T4 after thyroidectomy and ablation with iodine-131. ( Barroso, AL; Borges, MA; Costa, GB; Padrão, EL; Purisch, S; Rezende, LL; Rosário, PW, 2007)
"Differentiated thyroid cancers (DTC) often form metastases in neck lymph nodes, lungs and bones."1.33Hepatic metastasis of differentiated thyroid carcinoma. ( Kraft, O, 2005)
"Relative risk for thyroid cancer-related death and SMR are significantly increased in patients with stage T4 and M1 or advanced age."1.33Survival and death causes in differentiated thyroid carcinoma. ( Biermasz, NR; Corssmit, EP; Eustatia-Rutten, CF; Pereira, AM; Romijn, JA; Smit, JW, 2006)
"Hypothyroidism and hypoparathyroidism are common complications after treatment (surgery, radiotherapy and/or chemotherapy) for laryngo-pharyngeal carcinoma and other malignancies in the neck region."1.32[Clinical reasoning and decision making in practice. A man with unilateral attacks of muscular rigidity following neck surgery for a malignant tumor]. ( Bromberg, JE; Hart, W; Niermeijer, JM, 2003)
"Body weights were unaffected by PCN treatment, but were reduced 21% after 19 weeks of PCB treatment compared to control."1.32Promotion of thyroid tumors in rats by pregnenolone-16alpha-carbonitrile (PCN) and polychlorinated biphenyl (PCB). ( Habeebu, SM; Klaassen, CD; Muppidi, JR; Vansell, NR, 2004)
"Eleven patients with head and neck cancer (ten men, one woman; mean age, 65 years) (larynx, six; oropharynx, two; tongue, one; skin, one; thyroid, one) with regional lymph node enlargements either in contiguity or firmly adherent to the vascular structures of the neck have been treated by means of external microwaves (915, 434 MHz) applicators."1.28Serum thyroid hormone changes in head and neck cancer patients treated with microwave hyperthermia on lymph node metastasis. ( Airoldi, M; Brossa, PC; D'Alberto, M; Gabriele, P; Pedani, F; Ragona, R; Tseroni, V, 1990)
"Transition between thyroid and carcinoid occurred by proliferation of interfollicular cells which subtly formed trabecular structures."1.26Ovarian strumal carcinoid. An immunocytochemical and ultrastructural study of two cases. ( Ehrlich, CE; Roth, LM; Ulbright, TM, 1982)
"Plasma T3 levels were reduced in both breast cancer group, but were reduced only in colonic cancer patients with systemic metastases."1.26Plasma thyronine levels in carcinoma of the breast and colon. ( Davis, TE; Rose, DP, 1981)
"The reliability of pituitary suppression by administration of 1-thyroxin (t4) or a combination of thyroxin and triiodothyronin (t3) of variable dosage following radical surgery for thyroid cancer in 13 patients was investigated by means of TRH-test and measurement of serum hormone levels."1.25[Evaluation of reliable pituitary suppression therapy through varying thyroid hormone dosage following total thyroidectomy due to a differentiated thyroid carcinoma]. ( Hüfner, M; Papke, W; Röher, HD; Wahl, R, 1975)

Research

Studies (181)

TimeframeStudies, this research(%)All Research%
pre-199067 (37.02)18.7374
1990's26 (14.36)18.2507
2000's30 (16.57)29.6817
2010's56 (30.94)24.3611
2020's2 (1.10)2.80

Authors

AuthorsStudies
Toda, S1
Kadoya, M1
Matsui, A1
Murayama, D1
Iwasaki, H1
Huang, CH1
Huang, TY1
Chang, WJ1
Pan, YS1
Chu, HR1
Li, ZL1
Unson, S1
Chin, YT1
Lin, CY1
Huang, HM1
Hsiung, CN1
Gionfra, F1
De Vito, P1
Pedersen, JZ1
Incerpi, S1
Chen, YR1
Lee, SY1
Lin, HY1
Davis, PJ1
Whang-Peng, J1
Wang, K1
Miller, ML1
Peterson, ME1
Randolph, JF1
Broome, MR1
Norsworthy, GD1
Rishniw, M1
Bellantone, R1
Raffaelli, M1
De Crea, C1
Sessa, L1
Traini, E1
Princi, P1
Lombardi, CP1
Jin, S1
Yang, YT1
Bao, W1
Bai, Y1
Ai, JW1
Liu, Y1
Yong, H1
Hong, JT1
Lee, JH1
Kim, SH1
Hong, SB1
Nam, M1
Kim, YS1
Chu, YC1
Lin, Z2
Chen, L2
Fang, Y1
Cai, A1
Zhang, T1
Wu, VW2
Bernát, L1
Hrušák, D1
Ishikawa, M1
Tachibana, T1
Hashimoto, H2
Toyomura, J1
Ito, T1
Tsuboi, K1
Shibuya, K1
Hirose, T1
Minami, S2
Yoshino, G1
Vigário, Pdos S2
Chachamovitz, DS2
Teixeira, Pde F2
Rocque, Mde L1
Santos, ML1
Vaisman, M2
Ciappuccini, R1
Hardouin, J1
Heutte, N1
Vaur, D1
Quak, E1
Rame, JP1
Blanchard, D1
de Raucourt, D1
Bardet, S1
Santoro, AB1
Vargens, DD1
Barros Filho, Mde C1
Bulzico, DA1
Kowalski, LP1
Meirelles, RM1
Paula, DP1
Neves, RR1
Pessoa, CN1
Struchine, CJ1
Suarez-Kurtz, G1
Lee, DY1
Seok, J1
Jeong, WJ1
Ahn, SH1
Rosario, PW6
Calsolari, MR2
Naghibi, SM1
Ramezani, M1
Ayati, N1
Zakavi, SR1
Xia, Q1
Dong, S1
Bian, PD1
Wang, J1
Li, CJ1
Ito, M3
Miyauchi, A3
Kang, S1
Hisakado, M1
Yoshioka, W1
Ide, A1
Kudo, T2
Nishihara, E2
Kihara, M2
Ito, Y3
Kobayashi, K2
Miya, A2
Fukata, S1
Nakamura, H1
Amino, N2
Del Duca, SC1
Santaguida, MG1
Brusca, N1
Gatto, I1
Cellini, M1
Gargano, L1
Verga Falzacappa, C1
Frattaroli, FM1
Virili, C1
Centanni, M1
Atkins, F1
Van Nostrand, D1
Moreau, S1
Burman, K1
Wartofsky, L1
Handkiewicz-Junak, D1
Gawlik, T1
Rozkosz, J1
Puch, Z1
Michalik, B1
Gubala, E1
Krajewska, J1
Kluczewska, A1
Jarzab, B3
Coura-Filho, GB1
Willegaignon, J1
Buchpiguel, CA1
Sapienza, MT1
Batista, KC1
Dutta, S1
Biswas, KD1
Ghatak, S1
Haldar, D1
Sen, I1
Sinha, R1
Karls, S1
Abikhzer, G1
Tamilia, M1
Probst, S1
Ulusoy, E1
Edeer-Karaca, N1
Özen, S1
Ertan, Y1
Gökşen, D1
Aksu, G1
Darcan, Ş1
Kütükçüler, N1
Cecoli, F1
Andraghetti, G1
Ghiara, C1
Briatore, L1
Cavallero, D1
Mussap, M1
Minuto, F1
Giusti, M1
Panico, A1
Lupoli, GA1
Fonderico, F1
Marciello, F1
Martinelli, A1
Assante, R1
Lupoli, G1
Hirsch, D1
Ginat, M1
Levy, S1
Benbassat, C1
Weinstein, R1
Tsvetov, G1
Singer, J1
Shraga-Slutzky, I1
Grozinski-Glasberg, S1
Mansiterski, Y1
Shimon, I1
Reicher-Atir, R1
Heemstra, KA3
Burggraaf, J1
van der Klaauw, AA1
Romijn, JA5
Smit, JW5
Corssmit, EP4
Giovanella, L1
Maffioli, M1
Ceriani, L1
De Palma, D1
Spriano, G1
Nunes, Vdos S1
Tagliarini, JV1
Marques, ME1
de Godoi, JA1
Mazeto, GM1
Abdulrahman, RM1
Verloop, H1
Hoftijzer, H1
Verburg, E1
Hovens, GC1
Reiners, C3
Gelderblom, H1
Pereira, AM2
Kapiteijn, E1
Visser, TJ1
Reverter, JL3
Colomé, E2
Puig Domingo, M1
Julián, T1
Halperin, I1
Sanmartí, A3
Gómez Sáez, JM1
Holgado, S2
Aguilera, E1
Soldevila, B1
Mateo, L1
Lin, J1
Feng, H1
Emerson, CH1
Eisenberg, MC1
Santini, F1
Marsili, A1
Pinchera, A2
DiStefano, JJ1
Franco, AT1
Malaguarnera, R1
Refetoff, S2
Liao, XH1
Lundsmith, E1
Kimura, S1
Pritchard, C1
Marais, R1
Davies, TF1
Weinstein, LS1
Chen, M1
Rosen, N1
Ghossein, R1
Knauf, JA1
Fagin, JA1
Konrády, A1
Paragliola, RM1
Lovicu, RM1
Locantore, P1
Senes, P1
Concolino, P1
Capoluongo, E1
Pontecorvi, A1
Corsello, SM1
Santos, MA1
Oliveira, FP1
Binz, K1
Haldemann, A1
Meier, CA1
Bohinc, BN1
Parker, JC1
Hope, WW1
Kotwall, C1
Turner, J1
Cheng, W1
Lloyd, RV1
Triggiani, V1
Guastamacchia, E1
Renzulli, G1
Giagulli, VA1
Tafaro, E1
Licchelli, B1
Resta, F1
Sabbà, C1
Bagnulo, R1
Lastella, P1
Stella, A1
Resta, N1
Klein, HA1
Malehmir, M1
Haghpanah, V1
Larijani, B1
Ahmadian, S1
Alimoghaddam, K1
Heshmat, R1
Ghavamzadeh, A1
Adabi, K1
Ghaffari, SH1
Meringolo, D1
Bianchi, D1
Capula, C1
Costante, G1
Sugitani, I1
Fujimoto, Y3
Tanaka, K2
Sonoo, H1
Byrd, JK1
Yawn, RJ1
Wilhoit, CS1
Sora, ND1
Meyers, L1
Fernandes, J1
Day, T1
Fiore, E1
Vitti, P1
Sisson, JC1
Giordano, TJ1
Avram, AM1
Pacini, F2
Castagna, MG2
Hadfield, CA1
Clayton, LA1
Clancy, MM1
Beck, SE1
Mangus, LM1
Montali, RJ1
Tomoda, C1
Morita, S1
Takamura, Y1
Kubota, S1
Park, DJ1
Lim, JA1
Kim, TH1
Choi, HS1
Ahn, HY1
Lee, EK1
Lee, YJ1
Kim, KW1
Park, YJ1
Yi, KH1
Cho, BY2
Lee, JI1
Chung, YJ1
Park, SJ1
Ryu, HS1
Yamazaki, CA1
Padovani, RP1
Biscolla, RP1
Ikejiri, ES1
Marchetti, RR1
Castiglioni, ML1
Matsumura, LK1
Maciel, RM2
Furlanetto, RP1
Schneider, R1
Schneider, M1
Schneider, P1
Psaltakos, V1
Balatsouras, DG1
Sengas, I1
Ferekidis, E1
Riga, M1
Korres, SG1
Mikosch, P1
Obermayer-Pietsch, B1
Jost, R1
Jauk, B1
Gallowitsch, HJ1
Kresnik, E1
Leb, G1
Lind, P1
BALME, HW1
FLECK, F1
SALVATORE, G1
HALES, IB1
REEVE, TS1
STANLEY, PG1
MYHILL, J1
RICHARDS, M1
Bromberg, JE1
Niermeijer, JM1
Hart, W1
Vansell, NR1
Muppidi, JR1
Habeebu, SM1
Klaassen, CD1
Salvatori, M1
Perotti, G1
Rufini, V1
Maussier, ML1
Dottorini, M1
Cardoso, LD2
Fagundes, TA2
Reis, JS1
Maia, FF1
Purisch, S4
Kraft, O1
Eustatia-Rutten, CF2
Biermasz, NR1
Alonso, N1
Salinas, I1
Granada, ML1
Karner, I1
Hrgović, Z1
Sijanović, S1
Buković, D1
Klobucar, A1
Usadel, KH1
Fassbender, WJ1
Padrão, EL3
Rezende, LL3
Barroso, AL3
Jiang, JY1
Tseng, FY1
Vasconcelos, FP1
Lauria, MW1
Guimarães, VC1
Hamdy, NA1
Sajjinanont, T1
Rajchadara, S1
Sriassawaamorn, N1
Panichkul, S1
Nakagawa, Y1
Mori, K1
Hoshikawa, S1
Ozaki, H1
Ito, S1
Yoshida, K1
Dedecjus, M1
Kołomecki, K1
Brzeziński, J1
Adamczewski, Z1
Tazbir, J1
Lewiński, A1
Heijboer, AC1
Frölich, M1
Borges, MA1
Costa, GB1
McLaughlin, CM1
Hunter, SJ1
Bell, PM1
McCance, DR1
Sheridan, B1
Atkinson, AB1
Pelttari, H1
Laitinen, K1
Schalin-Jäntti, C1
Välimäki, MJ1
Harvard, CW1
Tegler, L1
Gillquist, J1
Lindvall, R1
Almqvist, S1
Appelqvist, P1
Kostianinen, S1
Demidov, VP1
Agranat, VZ1
Ol'shanskiĭ, VO1
Babakulyeva, D1
Voronetskiĭ, IB1
Mizukami, Y1
Matsubara, F1
Hashimoto, T1
Haratake, J1
Terahata, S1
Noguchi, M1
Hirose, K1
Rose, DP1
Davis, TE1
Arnold, DL1
Krewski, DR1
Junkins, DB1
McGuire, PF1
Moodie, CA1
Munro, IC1
Feldt-Rasmussen, U1
Holten, I1
Hansen, HS1
Ishii, H1
Inada, M2
Mashio, Y1
Naito, K1
Nishikawa, M1
Imura, H1
Thomas, CG1
Rutledge, RG1
Ulbright, TM1
Roth, LM1
Ehrlich, CE1
Kawaoi, A1
Okano, T1
Nemoto, N1
Shiina, Y1
Shikata, T1
Simpson, WJ1
Prinz, RA1
Oslapas, R1
Hofmann, C1
Shah, KH1
Ernst, K1
Refsguard, J1
Lawrence, AM1
Paloyan, E1
Börner, W1
Ohara, T1
Richards, GE1
Brewer, ED1
Conley, SB1
Saldana, LR1
Clark, OH1
Gemsenjäger, E1
Girard, J1
Sethi, VK1
Waldstein, SS1
David, E1
Rosen, IB1
Bain, J1
James, J1
Kirsh, JC1
Fujiyama, K1
Kiriyama, T1
Kimura, H1
Ashizawa, K1
Tsuruta, M1
Nagayama, Y1
Villadolid, MC1
Yokoyama, N1
Nagataki, S1
Lecomte, P1
Lecureuil, N1
Osorio-Salazar, C1
Lecureuil, M1
Valat, C1
Francia, G1
Davì, MV1
Petroziello, A1
Sussi, PL1
Smith, CD1
Ain, KB1
Staunton, MD2
Marks, SL1
Koblik, PD1
Hornof, WJ1
Feldman, EC1
Stracke, H1
Federlin, K1
Görres, G1
Kaim, A1
Otte, A1
Götze, M1
Müller-Brand, J1
Kung, AW1
Yeung, SS1
Lukinac, L1
Franceschi, M1
Nöthig-Hus, D1
Lechpammer, S1
Tomasić, J1
Vranesić, B1
Pape, E1
Kusić, Z1
Haber, RS1
Pujol, P1
Osman, A1
Bringer, J1
Jaffiol, C1
Feldkamp, J1
López Alvarez, MB1
Hawkins, F1
Rigopoulou, D1
Martínez, G1
Jodar, E1
Estenoz, J1
Ortuño, B1
Arnaiz, F1
Alagöl, F1
Tanakol, R1
Boztepe, H1
Kapran, Y1
Terzioglu, T1
Dizdaroglu, F1
Girelli, ME1
Casara, D1
Rubello, D1
Mazzarotto, R1
Saladini, G1
Busnardo, B1
Almeida-Filho, P1
Ravizzini, GC1
Almeida, C1
Borges-Neto, S1
Yasuhara, K1
Koujitani, T1
Takegawa, K1
Nasu, M1
Onodera, H1
Takagi, H1
Hirose, M1
Mitsumori, K1
Kowalczyk, P2
Sielańczyk, A1
Nowak, J1
Matuszewska, G1
Roskosz, J2
Czernik, E2
Gubała, E2
Jurecka-Tuleja, B1
Molinaro, E1
Lippi, F1
Agate, L1
Ceccarelli, C1
Taddei, D1
Elisei, R1
Capezzone, M1
Harrison, J1
Karanfilski, BT1
Kaplan, EL1
De Groot, LJ1
Bekerman, C1
Nagasaka, A1
Hidaka, H1
Arango, A1
Lester, JL1
Martinez, OV1
Malinin, TI1
Zeppa, R1
Thom, AF1
Marquezine, FJ1
Kieffer, J1
Ferraz, AR1
Netto, A1
Toledo, AC1
Hasen, J1
Goldiner, M1
Volpert, EM1
Prezyna, AP1
Gaeta, JF1
Koepf, GF1
Wahl, R1
Hüfner, M1
Röher, HD2
Papke, W1
Greening, WP1
Grabein, H1
Wedell, J1
van Calker, H1
Gabuniia, RI1
Romanova, LF1
Pinkera, A1
Matiakin, EG1
Duditskaia, TK1
Verschueren, CP1
Selman, PJ1
Mol, JA1
Vos, JH1
van Dijk, JE1
Sjollema, BE1
de Vijlder, JJ1
Diamond, T1
Nery, L1
Hales, I1
Hiasa, Y2
Kitahori, Y2
Kitamura, M1
Nishioka, H1
Yane, K1
Fukumoto, M1
Ohshima, M2
Nakaoka, S1
Nishii, S1
Airoldi, M1
Gabriele, P1
Brossa, PC1
Pedani, F1
Tseroni, V1
D'Alberto, M1
Ragona, R1
Harvey, RD1
Matheson, NA1
Grabowski, PS1
Rodger, AB1
Langer, HJ1
Leicht, E1
Koch, B1
Weinheimer, B1
Berberich, R1
Strohfeldt, P1
Weinges, KF1
Wang, RL1
Tan, YB1
Lee, JK1
Gordon, PR1
Stall, GM1
Gilchrest, BA1
Kaplan, MM1
Matsuki, H1
Konishi, N1
Thamavit, W1
Poston, GJ1
Thomas, AM1
Macdonald, DW1
Karvounaris, D1
Henderson, BL1
George, P1
Lynn, JA1
Lavender, JP1
Schlumberger, M1
De Vathaire, F1
Wu-Ahouju, G1
Comoy, E1
Fragu, P1
Parmentier, C1
Baschieri, L1
Antonelli, A1
Del Guerra, P1
Athanassiades, P1
Piperingos, G1
Pandos, P1
Koutras, D1
Moulopoulos, S1
Lam, KS1
Tse, VK1
Wang, C1
Yeung, RT1
Ma, JT1
Ho, JH1
Vilde, F1
Gehin-Fouque, F1
Etling, N1
Dedenkov, AN1
Petrova, GA1
Smoryzanova, OA1
Norets, TA1
Vereshchagina, GV1
Välimäki, M1
Lamberg, BA1
Spitsa, AI2
Arkhipenko, VI2
Ouchi, Y1
Ouchi, S1
Hachiya, T1
Yoshimura, M1
Abe, S1
Pochin, EE1
Gutmann, L1
Crosby, TW1
Takamori, M1
Martin, JD1
Bellabarba, D1
Varsano-Aharon, N1
Sterling, K1
Melander, A1
Thomas-Morvan, C1
Nataf, B1
Tubiana, M1
Richardson, JE1
Wade, JS1
Samaan, NA1
Beceiro, JR1
Hill, CS1
Haynie, TP1
Glenn, HJ1
Shah, DH1
Thakare, UR1
Shownkeen, RC1
Pahuja, DN1
Mandlik, MY1
Hill, LD1
Beebe, HG1
Hipp, R1
Jones, HW1
Desai, KB1
Mehta, MN1
Patel, MC1
Sharma, SM1
Ramanna, L1
Ganatra, RD1
McKenzie, JM1
Murphy, SS1
Gubler, R1
Meyer, BJ1
Bieler, EU1
Jansen, CR1
Mayberry, WE1
Gharib, H1
Bilstad, JM1
Sizemore, GW1
Blackburn, G1
Bokelmann, D1
Dörr, D1
Linder, F1
Oellers, B1
Rudolph, H1
Trumm, FA1
Cherry, CP2
Glucksmann, A1
Taylor, S1
Davis, PW1
Glucksman, A1

Clinical Trials (4)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effects of Thyroid Hormone Withdrawal and Recombinant Human Thyroid Stimulating Hormone in Glomerular Filtration Rate During Radioiodine Therapy[NCT01945125]28 participants (Actual)Interventional2011-10-31Completed
Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma[NCT00887107]Phase 232 participants (Actual)Interventional2007-10-31Completed
Cognitive Functions and Mood During Thyrotropin Suppressive Therapy in Patients With Differentiated Thyroid Carcinoma[NCT02665325]100 participants (Anticipated)Observational2016-01-31Recruiting
Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples[NCT06133374]130 participants (Anticipated)Observational2023-12-31Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

16 reviews available for thyroxine and Carcinoma, Anaplastic

ArticleYear
Case of concurrent Riedel's thyroiditis, acute suppurative thyroiditis, and micropapillary carcinoma.
    The Korean journal of internal medicine, 2013, Volume: 28, Issue:2

    Topics: Anti-Bacterial Agents; Biopsy; Carcinoma; Carcinoma, Papillary; Female; Hashimoto Disease; Hormone R

2013
[Differentiated thyroid cancer -- 2009].
    Orvosi hetilap, 2011, Jan-30, Volume: 152, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Carcinoma; Carcinoma, Medullary

2011
[Differentiated thyroid carcinoma--essential for the practitioner].
    Therapeutische Umschau. Revue therapeutique, 2011, Volume: 68, Issue:6

    Topics: Carcinoma; Combined Modality Therapy; Humans; Iodine Radioisotopes; Radiopharmaceuticals; Thyroid Ne

2011
Papillary thyroid carcinoma in Peutz-Jeghers syndrome.
    Thyroid : official journal of the American Thyroid Association, 2011, Volume: 21, Issue:11

    Topics: AMP-Activated Protein Kinase Kinases; Biopsy, Fine-Needle; Carcinoma; Carcinoma, Papillary; Female;

2011
Well differentiated thyroid carcinoma: current treatment.
    Current treatment options in oncology, 2012, Volume: 13, Issue:1

    Topics: Carcinoma; Carcinoma, Papillary; Female; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; N

2012
Approach to and treatment of differentiated thyroid carcinoma.
    The Medical clinics of North America, 2012, Volume: 96, Issue:2

    Topics: Adenocarcinoma, Follicular; Carcinoma; Carcinoma, Papillary; Cell Differentiation; Combined Modality

2012
[Recombinant TSH in ablative therapy and follow-up of patients with differentiated thyroid carcinoma].
    Arquivos brasileiros de endocrinologia e metabologia, 2005, Volume: 49, Issue:3

    Topics: Carcinoma; Follow-Up Studies; Humans; Hypothyroidism; Iodine Radioisotopes; Neoplasm Recurrence, Loc

2005
[Will the thyroglobulin assay with lower functional sensitivity whilst the patients are on L-T4 treatment replace the TSH-stimulated thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer?].
    Arquivos brasileiros de endocrinologia e metabologia, 2007, Volume: 51, Issue:5

    Topics: Algorithms; Biological Assay; Carcinoma; Humans; Neoplasm Recurrence, Local; Neoplasm, Residual; Pra

2007
Conventional withdrawal of thyroid hormone before radioiodine therapy in differentiated thyroid carcinoma: how frequently are adequately raised TSH levels attained?
    Clinical endocrinology, 2008, Volume: 69, Issue:1

    Topics: Carcinoma; Cell Differentiation; Clinical Audit; Humans; Iodine Radioisotopes; Middle Aged; Radionuc

2008
The thyroid and ageing.
    Clinics in endocrinology and metabolism, 1981, Volume: 10, Issue:1

    Topics: Age Factors; Aged; Aging; Alpha-Globulins; Animals; Carcinoma; Humans; Hyperthyroidism; Hypothyroidi

1981
Multiple thoracotomy combined with chemotherapy in metastatic adrenal cortical carcinoma: a case report and review of the literature.
    Journal of surgical oncology, 1983, Volume: 24, Issue:1

    Topics: Adolescent; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Carcinoma; Cortisone; Cushing Syndrom

1983
Thyroid nodules and the detection of thyroid cancer.
    The Mount Sinai journal of medicine, New York, 1996, Volume: 63, Issue:1

    Topics: Adult; Aged; Carcinoma; Female; Humans; Male; Middle Aged; Patient Selection; Risk Factors; Thyroid

1996
[Endocrine therapy and after-care in thyroid gland carcinoma].
    Praxis, 1998, Mar-11, Volume: 87, Issue:11

    Topics: Aftercare; Carcinoma; Combined Modality Therapy; Humans; Neoplasm Staging; Thyroid Neoplasms; Thyrot

1998
Anaplastic thyroid cancer with transient thyrotoxicosis: case report and literature review.
    Thyroid : official journal of the American Thyroid Association, 1999, Volume: 9, Issue:10

    Topics: Biopsy; Carcinoma; Fatal Outcome; Female; Goiter, Nodular; Humans; Middle Aged; Propranolol; Thyroid

1999
Radioiodine therapy of thyroid cancer.
    Seminars in nuclear medicine, 1971, Volume: 1, Issue:4

    Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Biopsy; Bone Marrow Diseases; Carcinoma; Half-Life; Human

1971
Treatment of the thyroid nodule.
    Advances in internal medicine, 1971, Volume: 17

    Topics: Adenocarcinoma; Autopsy; Carcinoma; Carcinoma, Papillary; Diagnosis, Differential; Humans; Hyperthyr

1971

Trials

11 trials available for thyroxine and Carcinoma, Anaplastic

ArticleYear
Exercise is associated with better quality of life in patients on TSH-suppressive therapy with levothyroxine for differentiated thyroid carcinoma.
    Arquivos brasileiros de endocrinologia e metabologia, 2014, Volume: 58, Issue:3

    Topics: Adult; Autoantibodies; Carcinoma; Cross-Sectional Studies; Education; Exercise; Female; Humans; Hype

2014
Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer.
    British journal of clinical pharmacology, 2014, Volume: 78, Issue:5

    Topics: Adenocarcinoma, Follicular; Adult; Carcinoma; Carcinoma, Papillary; Cohort Studies; Dose-Response Re

2014
Effects of Thyroid Hormone Withdrawal and Recombinant Human Thyrotropin on Glomerular Filtration Rate During Radioiodine Therapy for Well-Differentiated Thyroid Cancer.
    Thyroid : official journal of the American Thyroid Association, 2015, Volume: 25, Issue:12

    Topics: Adult; Carcinoma; Chemoradiotherapy, Adjuvant; Combined Modality Therapy; Female; Glomerular Filtrat

2015
Radioiodine-induced oxidative stress in patients with differentiated thyroid carcinoma and effect of supplementation with vitamins C and E and selenium (antioxidants).
    Archives of endocrinology and metabolism, 2016, Volume: 60, Issue:4

    Topics: Adult; Analysis of Variance; Antioxidants; Ascorbic Acid; Carcinoma; Dietary Supplements; Dinoprost;

2016
Sorafenib-induced hypothyroidism is associated with increased type 3 deiodination.
    The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:8

    Topics: Aged; Aged, 80 and over; Benzenesulfonates; Carcinoma; Female; Humans; Hypothyroidism; Male; Middle

2010
Effect of postoperative thyrotropin suppressive therapy on bone mineral density in patients with papillary thyroid carcinoma: a prospective controlled study.
    Surgery, 2011, Volume: 150, Issue:6

    Topics: Adult; Aged; Bone Density; Carcinoma; Carcinoma, Papillary; Female; Follow-Up Studies; Humans; Middl

2011
Lithium as an adjuvant in the postoperative ablation of remnant tissue in low-risk thyroid carcinoma.
    Thyroid : official journal of the American Thyroid Association, 2012, Volume: 22, Issue:10

    Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Combined Modality Therapy; Female; Humans; Iodine Radi

2012
Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma.
    Endocrine-related cancer, 2005, Volume: 12, Issue:4

    Topics: Antineoplastic Agents; Bone Density; Bone Diseases, Metabolic; Carcinoma; Female; Femur Neck; Humans

2005
Influence of L-thyroxine administration on poor-platelet plasma VEGF concentrations in patients with induced short-term hypothyroidism, monitored for thyroid carcinoma.
    Endocrine journal, 2007, Volume: 54, Issue:1

    Topics: Blood Platelets; Carcinoma; Case-Control Studies; Cell Separation; Female; Humans; Hypothyroidism; M

2007
Glucose tolerance and lipid profile in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomised controlled trial.
    Clinical endocrinology, 2006, Volume: 65, Issue:6

    Topics: Adult; Carcinoma; Female; Glucose Intolerance; Humans; Hyperthyroidism; Insulin; Lipids; Male; Middl

2006
Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin.
    The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:3

    Topics: Biomarkers; Bone and Bones; Bone Density; Calcitonin; Calcium; Carcinoma; Female; Humans; Middle Age

1996

Other Studies

154 other studies available for thyroxine and Carcinoma, Anaplastic

ArticleYear
Hyperthyroidism due to thyrotropin receptor antibody stimulation of metastatic thyroid carcinoma during lenvatinib treatment: a case report.
    Annals of palliative medicine, 2022, Volume: 11, Issue:11

    Topics: Carcinoma; Humans; Hyperthyroidism; Iodine Radioisotopes; Male; Methimazole; Middle Aged; Thyroglobu

2022
Combined Treatment of Heteronemin and Tetrac Induces Antiproliferation in Oral Cancer Cells.
    Marine drugs, 2020, Jul-02, Volume: 18, Issue:7

    Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation,

2020
Thyroid Cysts in Cats: A Retrospective Study of 40 Cases.
    Journal of veterinary internal medicine, 2017, Volume: 31, Issue:3

    Topics: Animals; Carcinoma; Cat Diseases; Cats; Cystadenoma; Cysts; Female; Iodine Radioisotopes; Magnetic R

2017
Video-Assisted Thyroidectomy for Papillary Thyroid Carcinoma: Oncologic Outcome in Patients with Follow-Up ≥ 10 Years.
    World journal of surgery, 2018, Volume: 42, Issue:2

    Topics: Adolescent; Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Follow-Up Studies; Humans; Iodine

2018
Naming difficulties after thyroid stimulating hormone suppression therapy in patients with differentiated thyroid carcinoma: a prospective cohort study.
    Endocrine, 2019, Volume: 65, Issue:2

    Topics: Adult; Anomia; Carcinoma; Cognitive Dysfunction; Female; Hormone Replacement Therapy; Humans; Male;

2019
Longitudinal study on the correlations of thyroid antibody and thyroid hormone levels after radiotherapy in patients with nasopharyngeal carcinoma with radiation-induced hypothyroidism.
    Head & neck, 2014, Volume: 36, Issue:2

    Topics: Adult; Aged; Autoantibodies; Biomarkers; Carcinoma; Female; Follow-Up Studies; Humans; Hypothyroidis

2014
Hypothyroidism after radiotherapy of head and neck cancer.
    Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2014, Volume: 42, Issue:4

    Topics: Aged; Carcinoma; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Female; Follow-Up Studies;

2014
Functional analysis of three novel cell lines derived from human papillary thyroid carcinomas with three different clinical courses.
    Human cell, 2014, Volume: 27, Issue:3

    Topics: Adolescent; Adult; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Cell Line, Tumor; Cell Transf

2014
Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden.
    European journal of endocrinology, 2014, Volume: 171, Issue:2

    Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Humans; Iodine Rad

2014
Prediction of thyroid hormone supplementation after thyroid lobectomy.
    The Journal of surgical research, 2015, Volume: 193, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Hormone Replacement Therapy

2015
Should a family history of papillary thyroid carcinoma indicate more aggressive therapy in patients with this tumor?
    Arquivos brasileiros de endocrinologia e metabologia, 2014, Volume: 58, Issue:8

    Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Family Health; Female;

2014
Carum induced hypothyroidism: an interesting observation and an experiment.
    Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2015, Jan-24, Volume: 23

    Topics: Carcinoma; Carcinoma, Papillary; Carum; Female; Humans; Hypothyroidism; Thyroid Cancer, Papillary; T

2015
Effects of endocrine therapy on the prognosis of elderly patients after surgery for papillary thyroid carcinoma.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2016, Volume: 273, Issue:4

    Topics: Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; China; Female; Hormone Replacement Therapy

2016
Effect of the presence of remnant thyroid tissue on the serum thyroid hormone balance in thyroidectomized patients.
    European journal of endocrinology, 2015, Volume: 173, Issue:3

    Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Cohort Studies; Female; Hormone Replacement Therapy; H

2015
Individually-tailored thyroxine requirement in the same patients before and after thyroidectomy: a longitudinal study.
    European journal of endocrinology, 2015, Volume: 173, Issue:3

    Topics: Carcinoma; Dose-Response Relationship, Drug; Female; Hormone Replacement Therapy; Humans; Hypothyroi

2015
Validation of a Simple Thyroid Cancer Dosimetry Model Based on the Fractional Whole-Body Retention at 48 Hours Post-Administration of (131)I.
    Thyroid : official journal of the American Thyroid Association, 2015, Volume: 25, Issue:12

    Topics: Body Surface Area; Carcinoma; Female; Humans; Iodine Radioisotopes; Linear Models; Male; Radiometry;

2015
Recombinant human thyrotropin preparation for adjuvant radioiodine treatment in children and adolescents with differentiated thyroid cancer.
    European journal of endocrinology, 2015, Volume: 173, Issue:6

    Topics: Adenocarcinoma, Follicular; Adolescent; Carcinoma; Carcinoma, Papillary; Child; Humans; Iodine Radio

2015
Postoperative hypofunctioning of the thyroid gland after total laryngectomy.
    Ear, nose, & throat journal, 2016, Volume: 95, Issue:8

    Topics: Adult; Carcinoma; Follow-Up Studies; Humans; Hypothyroidism; India; Laryngeal Neoplasms; Laryngectom

2016
Interrupted 131I Procedures for Patients With Differentiated Thyroid Cancer: Comparing Thyroxine Withdrawal With Recombinant Thyrotropin Preparation Techniques.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:4

    Topics: Adult; Aged; Carcinoma; Drug Administration Schedule; Female; Humans; Iodine Radioisotopes; Male; Mi

2017
An unusual manifestation: Papillary thyroid carcinoma in a patient with ataxia-telengiectasia.
    The Turkish journal of pediatrics, 2016, Volume: 58, Issue:4

    Topics: Adolescent; Ataxia Telangiectasia; Carcinoma; Carcinoma, Papillary; Child; Female; Humans; Iodine Ra

2016
Absence of thyrotropin-induced increase in leptin levels in patients with history of differentiated thyroid carcinoma undergoing recombinant human thyrotropin testing.
    Journal of endocrinological investigation, 2008, Volume: 31, Issue:10

    Topics: Adult; Aged; Carcinoma; Female; Humans; Leptin; Middle Aged; Recombinant Proteins; Thyroid Neoplasms

2008
Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate.
    Thyroid : official journal of the American Thyroid Association, 2009, Volume: 19, Issue:5

    Topics: Adult; Alendronate; Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents;

2009
Illness perception in patients with differentiated epithelial cell thyroid cancer.
    Thyroid : official journal of the American Thyroid Association, 2009, Volume: 19, Issue:5

    Topics: Adaptation, Psychological; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Carcinom

2009
Short-term overt hypothyroidism induces sympathovagal imbalance in thyroidectomized differentiated thyroid carcinoma patients.
    Clinical endocrinology, 2010, Volume: 72, Issue:3

    Topics: Adult; Autonomic Nervous System; Carcinoma; Case-Control Studies; Catecholamines; Female; Heart Rate

2010
Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma.
    Clinical chemistry and laboratory medicine, 2009, Volume: 47, Issue:8

    Topics: Adult; Aged; Carcinoma; Female; Humans; Immunoradiometric Assay; Male; Middle Aged; Neoplasm Recurre

2009
A patient with Graves' disease and three types of thyroid carcinoma.
    Thyroid : official journal of the American Thyroid Association, 2010, Volume: 20, Issue:5

    Topics: Adenocarcinoma, Follicular; Aged; Carcinoma; Fatal Outcome; Female; Graves Disease; Humans; Neoplasm

2010
[Clinical endocrinologists' perception of the deleterious effects of TSH suppressive therapy in patients with differentiated thyroid carcinoma].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2010, Volume: 57, Issue:8

    Topics: Adult; Attitude of Health Personnel; Carcinoma; Cognition Disorders; Cross-Sectional Studies; Data C

2010
[Is our approach to thyroid nodules and differentiated thyroid carcinoma in agreement with the American guideline and European consensus?].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2010, Volume: 57, Issue:8

    Topics: Carcinoma; Consensus Development Conferences as Topic; Cross-Sectional Studies; Data Collection; Dru

2010
Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine treatment for differentiated thyroid carcinoma.
    Endocrine, 2010, Volume: 37, Issue:3

    Topics: Bone Density; Carcinoma; Fractures, Bone; Humans; Male; Thyroid Neoplasms; Thyroxine; Vitamin D

2010
A longitudinal study on the radiation-induced thyroid gland changes after external beam radiotherapy of nasopharyngeal carcinoma.
    Thyroid : official journal of the American Thyroid Association, 2011, Volume: 21, Issue:1

    Topics: Adult; Aged; Carcinoma; Female; Humans; Longitudinal Studies; Male; Middle Aged; Nasopharyngeal Carc

2011
Anthropomorphic thyroidopathies?
    Thyroid : official journal of the American Thyroid Association, 2010, Volume: 20, Issue:11

    Topics: Adult; Body Mass Index; Carcinoma; Child, Preschool; Fasting; Humans; Hypothyroidism; Insulin; Lepti

2010
TSH regulation dynamics in central and extreme primary hypothyroidism.
    Thyroid : official journal of the American Thyroid Association, 2010, Volume: 20, Issue:11

    Topics: Carcinoma; Circadian Rhythm; Computer Simulation; Feedback; Humans; Hypothyroidism; Iodine Radioisot

2010
Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice.
    Proceedings of the National Academy of Sciences of the United States of America, 2011, Jan-25, Volume: 108, Issue:4

    Topics: Animals; Carcinoma; Carcinoma, Papillary; Female; Gene Expression; Humans; Immunohistochemistry; Iod

2011
Differentiated thyroid cancer in two patients with resistance to thyroid hormone.
    Thyroid : official journal of the American Thyroid Association, 2011, Volume: 21, Issue:7

    Topics: Carcinoma; Carcinoma, Papillary; Humans; Male; Middle Aged; Thyroid Cancer, Papillary; Thyroid Hormo

2011
Impaired functional and hemodynamic response to graded exercise testing and its recovery in patients with subclinical hyperthyroidism.
    Arquivos brasileiros de endocrinologia e metabologia, 2011, Volume: 55, Issue:3

    Topics: Adaptation, Physiological; Blood Pressure; Carcinoma; Epidemiologic Methods; Exercise Test; Female;

2011
Micropapillary thyroid carcinoma and concomitant ectopic thyroid tissue in the adrenal gland: metastasis or metaplasia?
    Thyroid : official journal of the American Thyroid Association, 2011, Volume: 21, Issue:9

    Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Antineoplastic Agents; Biomarkers, Tumor; Biopsy; C

2011
Radioiodine dilution due to levothyroxine when using recombinant human thyroid-stimulating hormone: case report and discussion.
    Clinical nuclear medicine, 2011, Volume: 36, Issue:10

    Topics: Aged; Carcinoma; Carcinoma, Papillary; Humans; Indicator Dilution Techniques; Iodine Radioisotopes;

2011
Multifaceted suppression of aggressive behavior of thyroid carcinoma by all-trans retinoic acid induced re-differentiation.
    Molecular and cellular endocrinology, 2012, Jan-02, Volume: 348, Issue:1

    Topics: Antigens, Differentiation; Antineoplastic Agents; Carcinoma; Cell Dedifferentiation; Cell Differenti

2012
Papillary thyroid microcarcinoma in struma ovarii.
    Endocrine, 2012, Volume: 41, Issue:1

    Topics: Carcinoma; Carcinoma, Papillary; Female; Humans; Hysterectomy; Middle Aged; Ovarian Neoplasms; Strum

2012
Current trends in TSH suppression therapy for patients with papillary thyroid carcinoma in Japan: results of a questionnaire distributed to councilors of the Japanese Society of Thyroid Surgery.
    Surgery today, 2012, Volume: 42, Issue:7

    Topics: Carcinoma; Carcinoma, Papillary; Chemotherapy, Adjuvant; Female; Humans; Iodine Radioisotopes; Japan

2012
Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease.
    The Journal of clinical endocrinology and metabolism, 2012, Volume: 97, Issue:4

    Topics: Animals; Carcinoma; Carcinoma, Papillary; Humans; Molecular Targeted Therapy; Neoplasm Staging; Prac

2012
Three endocrine neoplasms: an unusual combination of pheochromocytoma, pituitary adenoma, and papillary thyroid carcinoma.
    Thyroid : official journal of the American Thyroid Association, 2012, Volume: 22, Issue:4

    Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Anti-Inflammatory Agents; Biopsy, Fine

2012
Proliferative thyroid lesions in three diplodactylid geckos: Nephrurus amyae, Nephrurus levis, and Oedura marmorata.
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2012, Volume: 43, Issue:1

    Topics: Animals; Animals, Zoo; Carcinoma; Fatal Outcome; Hyperplasia; Hypothyroidism; Lizards; Male; Thyroid

2012
Undetectable serum thyroglobulin levels in patients with medullary thyroid carcinoma after total thyroidectomy without radioiodine ablation.
    Thyroid : official journal of the American Thyroid Association, 2012, Volume: 22, Issue:7

    Topics: Adult; Aged; Carcinoma; Carcinoma, Neuroendocrine; Carcinoma, Papillary; Female; Humans; Male; Middl

2012
TSH-suppressive doses of levothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who have undergone total thyroidectomy.
    European journal of endocrinology, 2012, Volume: 167, Issue:3

    Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Humans; Male; Middle Aged; Preoperative Care;

2012
Serum thyroglobulin level measured after thyroxine withdrawal is useful to predict further recurrence in whole body scan-negative papillary thyroid cancer patients after reoperation.
    Endocrine journal, 2012, Volume: 59, Issue:11

    Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Humans; Male; Middle Aged; Neck; Neoplasm Recu

2012
Euthyroid status after total thyroidectomy due to functioning lung metastases from a clear cell variant of papillary thyroid carcinoma.
    Thyroid : official journal of the American Thyroid Association, 2012, Volume: 22, Issue:10

    Topics: Carcinoma; Carcinoma, Papillary; Female; Humans; Iodine Radioisotopes; Lung Neoplasms; Radionuclide

2012
Effects of levothyroxine on bone mineral density, muscle force, and bone turnover markers: a cohort study.
    The Journal of clinical endocrinology and metabolism, 2012, Volume: 97, Issue:11

    Topics: Adult; Bone Density; Carcinoma; Cohort Studies; Female; Goiter; Hormone Replacement Therapy; Humans;

2012
Cochlear dysfunction in patients with acute hypothyroidism.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2013, Volume: 270, Issue:11

    Topics: Acoustic Impedance Tests; Adult; Audiometry, Pure-Tone; Auditory Threshold; Carcinoma; Case-Control

2013
Bone metabolism in patients with differentiated thyroid carcinoma receiving suppressive levothyroxine treatment.
    Thyroid : official journal of the American Thyroid Association, 2003, Volume: 13, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone and Bones; Carcinoma; Dose-Response Relationship, D

2003
Metastatic carcinoma of the thyroid successfully treated with thyroxine.
    Lancet (London, England), 1954, Apr-17, Volume: 266, Issue:6816

    Topics: Carcinoma; Humans; Lung Neoplasms; Neoplasms; Thyroid Gland; Thyroid Neoplasms; Thyroxine

1954
[Treatment of roentgen carcinoma by hypervitaminization with axerophtholen].
    Dermatologische Wochenschrift, 1954, Volume: 130, Issue:47

    Topics: Carcinoma; Humans; Skin Neoplasms; Thyroxine; Vitamin A

1954
[INTRACELLULAR PENETRATION OF THYROID HORMONES].
    Exposes annuels de biochimie medicale, 1964, Volume: 25

    Topics: Animals; Carcinoma; Carcinoma, Ehrlich Tumor; Chromatography; Electrophoresis; Erythrocytes; Escheri

1964
FUNCTIONING FOLLICULAR METASTATIC CARCINOMA OF THE THYROID.
    The Medical journal of Australia, 1964, Oct-31, Volume: 2

    Topics: Carcinoma; Humans; Iodine Isotopes; Neoplasm Metastasis; Neoplasms; Pathology; Pharmacology; Thoraci

1964
[Clinical reasoning and decision making in practice. A man with unilateral attacks of muscular rigidity following neck surgery for a malignant tumor].
    Nederlands tijdschrift voor geneeskunde, 2003, Oct-25, Volume: 147, Issue:43

    Topics: Calcium; Carcinoma; Chemotherapy, Adjuvant; Diagnosis, Differential; Humans; Hypoparathyroidism; Mag

2003
Promotion of thyroid tumors in rats by pregnenolone-16alpha-carbonitrile (PCN) and polychlorinated biphenyl (PCB).
    Toxicological sciences : an official journal of the Society of Toxicology, 2004, Volume: 81, Issue:1

    Topics: Adenoma; Animals; Antithyroid Agents; Body Weight; Carcinoma; Chlorodiphenyl (54% Chlorine); Eating;

2004
Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan?
    Clinical endocrinology, 2004, Volume: 61, Issue:6

    Topics: Adolescent; Adult; Aged; Carcinoma; Child; Combined Modality Therapy; Female; Humans; Iodine Radiois

2004
[Usefulness of radioiodine scanning in patients with moderate/high risk differentiated thyroid carcinoma in whom thyroglobulin after thyroxin withdrawal is undetectable after initial treatment].
    Arquivos brasileiros de endocrinologia e metabologia, 2004, Volume: 48, Issue:3

    Topics: Aged; Aged, 80 and over; Carcinoma; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Radionu

2004
Hepatic metastasis of differentiated thyroid carcinoma.
    Nuclear medicine review. Central & Eastern Europe, 2005, Volume: 8, Issue:1

    Topics: Aged; Aged, 80 and over; Carcinoma; Cell Differentiation; Humans; Iodine Radioisotopes; Liver; Liver

2005
Survival and death causes in differentiated thyroid carcinoma.
    The Journal of clinical endocrinology and metabolism, 2006, Volume: 91, Issue:1

    Topics: Adult; Age Factors; Aged; Analysis of Variance; Carcinoma; Cause of Death; Endpoint Determination; F

2006
Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
    European journal of medical research, 2005, Nov-16, Volume: 10, Issue:11

    Topics: Absorptiometry, Photon; Adult; Biomarkers; Bone and Bones; Bone Density; Calcium; Carcinoma; Cohort

2005
Prognostic factors of anaplastic thyroid carcinoma.
    Journal of endocrinological investigation, 2006, Volume: 29, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Combined Modality Therapy; Female; Goiter; Humans; Leukoc

2006
Managing thyroid cancer without thyroxine withdrawal.
    Arquivos brasileiros de endocrinologia e metabologia, 2006, Volume: 50, Issue:1

    Topics: Adult; Carcinoma; Case-Control Studies; Cholesterol, LDL; Creatine Kinase; Female; Humans; Immunorad

2006
The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma.
    Thyroid : official journal of the American Thyroid Association, 2006, Volume: 16, Issue:6

    Topics: Adult; Aged; Bone and Bones; Carcinoma; Cell Differentiation; Databases, Bibliographic; Female; Huma

2006
The comparative study of bone mineral density between premenopausal women receiving long term suppressive doses of levothyroxine for well-differentiated thyroid cancer with healthy premenopausal women.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2005, Volume: 88 Suppl 3

    Topics: Adult; Bone Density; Carcinoma; Case-Control Studies; Drug Administration Schedule; Female; Humans;

2005
Development of subclinical hyperthyroidism due to Graves' disease in a hypothyroid woman who had undergone hemithyroidectomy for adenomatous goiter and radiotherapy for nasopharyngeal cancer.
    Endocrine journal, 2007, Volume: 54, Issue:1

    Topics: Adult; Carcinoma; Female; Goiter, Nodular; Graves Disease; Hormone Replacement Therapy; Humans; Hype

2007
Management of low-risk patients with thyroid carcinoma and detectable thyroglobulin on T4 after thyroidectomy and ablation with iodine-131.
    Arquivos brasileiros de endocrinologia e metabologia, 2007, Volume: 51, Issue:1

    Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Carcinoma; Female; Humans; Iodine Radioisotopes; Lung Ne

2007
Long-term outcome of 495 TNM stage I or II patients with differentiated thyroid carcinoma followed up with neck ultrasonography and thyroglobulin measurements on T4 treatment.
    Clinical endocrinology, 2008, Volume: 69, Issue:2

    Topics: Adolescent; Adult; Aged; Carcinoma; Cell Differentiation; Child; Female; Follow-Up Studies; Hormone

2008
Secretion rates of thyroxine, triiodothyronine, and reverse triiodothyronine in man during surgery.
    Acta endocrinologica, 1982, Volume: 101, Issue:2

    Topics: Adenoma; Adult; Aged; Carcinoma; Electromagnetic Phenomena; Female; Goiter; Goiter, Nodular; Humans;

1982
[Hormone-secreting tumors in the thyroid and parathyroid glands. Morphological studies].
    Nihon rinsho. Japanese journal of clinical medicine, 1983, Volume: 41, Issue:6

    Topics: Adenocarcinoma; Calcitonin; Carcinoma; Humans; Parathyroid Neoplasms; Thyroid Neoplasms; Thyroxine

1983
[Thyroid activity in patients with thyroid neoplasms].
    Voprosy onkologii, 1983, Volume: 29, Issue:11

    Topics: Adenoma; Adolescent; Adult; Age Factors; Aged; Carcinoma; Female; Humans; Male; Middle Aged; Sex Fac

1983
Primary mucoepidermoid carcinoma in the thyroid gland. A case report including an ultrastructural and biochemical study.
    Cancer, 1984, Apr-15, Volume: 53, Issue:8

    Topics: Adenocarcinoma; Adult; Carcinoma; Diagnosis, Differential; Female; Humans; Lymph Nodes; Microscopy,

1984
Plasma thyronine levels in carcinoma of the breast and colon.
    Archives of internal medicine, 1981, Volume: 141, Issue:9

    Topics: Adult; Breast Neoplasms; Carcinoma; Colonic Neoplasms; Female; Humans; Liver Neoplasms; Middle Aged;

1981
Reversibility of ethylenethiourea-induced thyroid lesions.
    Toxicology and applied pharmacology, 1983, Volume: 67, Issue:2

    Topics: Adenoma; Animals; Body Weight; Carcinoma; Diet; Dose-Response Relationship, Drug; Ethylenethiourea;

1983
Influence of thyroid substitution therapy and thyroid autoantibodies on the value of serum thyroglobulin in recurring thyroid cancer.
    Cancer, 1983, Jun-15, Volume: 51, Issue:12

    Topics: Adolescent; Adult; Aged; Autoantibodies; Carcinoma; Female; Follow-Up Studies; Humans; Male; Methods

1983
Triiodothyronine generation from thyroxine in human thyroid: enhanced conversion in Graves' thyroid tissue.
    The Journal of clinical endocrinology and metabolism, 1981, Volume: 52, Issue:6

    Topics: Adenoma; Carcinoma; Dithiothreitol; Graves Disease; Humans; Hydrogen-Ion Concentration; Kinetics; Th

1981
Surgical intervention in chronic (Hashimoto's) thyroiditis.
    Annals of surgery, 1981, Volume: 193, Issue:6

    Topics: Adult; Aged; Biopsy, Needle; Carcinoma; Diagnosis, Differential; Female; Goiter, Nodular; Humans; Io

1981
Ovarian strumal carcinoid. An immunocytochemical and ultrastructural study of two cases.
    American journal of clinical pathology, 1982, Volume: 77, Issue:5

    Topics: Aged; Calcitonin; Carcinoid Tumor; Carcinoma; Female; Humans; Immunoenzyme Techniques; Middle Aged;

1982
Simultaneous detection of thyroglobulin (Tg), thyroxine (T4), and Triiodothyronine (T3) in nontoxic thyroid tumors by the immunoperoxidase method.
    The American journal of pathology, 1982, Volume: 108, Issue:1

    Topics: Adenocarcinoma; Adenoma; Carcinoma; Carcinoma, Papillary; Carcinoma, Squamous Cell; Cystadenoma; Hum

1982
Thyroid malignancy in the elderly.
    Geriatrics, 1982, Volume: 37, Issue:3

    Topics: Adenocarcinoma; Aged; Carcinoma; Carcinoma, Papillary; Carcinoma, Squamous Cell; Fibrosarcoma; Human

1982
Long-term effect of radiation on thyroid function and tumor formation.
    The Journal of surgical research, 1982, Volume: 32, Issue:4

    Topics: Adenocarcinoma; Adenoma; Animals; Brain Neoplasms; Calcitonin; Carcinoma; Female; Male; Medulla Oblo

1982
[Specific follow-up program for thyroid cancer].
    Medizinische Klinik (Praxis-Ausg.), 1982, Aug-27, Volume: 77, Issue:18

    Topics: Carcinoma; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Postoperative Care; Radionuclide

1982
[Endocrine aspects of thyroid cancer].
    Horumon to rinsho. Clinical endocrinology, 1982, Volume: 30, Issue:8

    Topics: Adenocarcinoma, Papillary; Adult; Aged; Calcitonin; Carcinoma; Female; Humans; Male; Middle Aged; Th

1982
Combined hypothyroidism and hypoparathyroidism in an infant after maternal 131I administration.
    The Journal of pediatrics, 1981, Volume: 99, Issue:1

    Topics: Carcinoma; Female; Humans; Hypocalcemia; Hypoparathyroidism; Hypothyroidism; Infant; Infant, Newborn

1981
TSH suppression in the management of thyroid nodules and thyroid cancer.
    World journal of surgery, 1981, Volume: 5, Issue:1

    Topics: Adenoma; Carcinoma; Goiter; Humans; Thyroid Diseases; Thyroid Hormones; Thyroid Neoplasms; Thyroidit

1981
[Preclinical hyperthyroidism in thyroid invasion by tumors of other organs].
    Schweizerische medizinische Wochenschrift, 1981, Oct-17, Volume: 111, Issue:42

    Topics: Adenocarcinoma; Carcinoma; Female; Humans; Hyperthyroidism; Kidney Neoplasms; Lymphoma; Male; Middle

1981
Non-surgical treatment of thyroid carcinoma.
    Annals of the Academy of Medicine, Singapore, 1981, Volume: 10, Issue:3

    Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Carcinoma; Humans; Iodine Radioisotopes; Thyroid Neoplasm

1981
Suppressive therapy in the management of metastatic thyroid carcinoma.
    Otolaryngologic clinics of North America, 1980, Volume: 13, Issue:1

    Topics: Adenocarcinoma; Anaplasia; Carcinoma; Carcinoma, Papillary; Humans; Neoplasm Metastasis; Thyroid Neo

1980
Management of the hot thyroid nodule.
    American journal of surgery, 1995, Volume: 170, Issue:5

    Topics: Adenocarcinoma; Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; D

1995
Suppressive doses of thyroxine do not accelerate age-related bone loss in late postmenopausal women.
    Thyroid : official journal of the American Thyroid Association, 1995, Volume: 5, Issue:1

    Topics: Aged; Aging; Bone Density; Carcinoma; Cross-Sectional Studies; Dose-Response Relationship, Drug; Fem

1995
Effects of suppressive doses of levothyroxine treatment on sex-hormone-binding globulin and bone metabolism.
    Thyroid : official journal of the American Thyroid Association, 1995, Volume: 5, Issue:1

    Topics: Adult; Body Weight; Bone and Bones; Bone Density; Carcinoma; Female; Goiter; Humans; Liver; Middle A

1995
[Hormonal therapy in differentiated carcinoma of the thyroid gland].
    Chirurgia italiana, 1994, Volume: 46, Issue:4

    Topics: Adenocarcinoma, Follicular; Adenylyl Cyclases; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; H

1994
Brain metabolism in hypothyroidism studied with 31P magnetic-resonance spectroscopy.
    Lancet (London, England), 1995, Mar-11, Volume: 345, Issue:8950

    Topics: Acute Disease; Adult; Brain; Carcinoma; Energy Metabolism; Humans; Hypothyroidism; Magnetic Resonanc

1995
Thyroid cancer: a multivariate analysis on influence of treatment on long-term survival.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 1994, Volume: 20, Issue:6

    Topics: Adenocarcinoma, Follicular; Adult; Carcinoma; Carcinoma, Papillary; Combined Modality Therapy; Femal

1994
99mTc-pertechnetate imaging of thyroid tumors in dogs: 29 cases (1980-1992).
    Journal of the American Veterinary Medical Association, 1994, Mar-01, Volume: 204, Issue:5

    Topics: Adenocarcinoma; Adenoma; Animals; Carcinoma; Carcinoma, Medullary; Dog Diseases; Dogs; Female; Lung

1994
BGP serum levels in patients with thyroid carcinoma before and 4-14 weeks after radioiodine therapy.
    Experimental and clinical endocrinology, 1993, Volume: 101, Issue:3

    Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Carcinoma; Female; Humans; Iodine Radioisotopes; Male

1993
Bone mineral density in patients receiving suppressive doses of thyroxine for differentiated thyroid carcinoma.
    European journal of nuclear medicine, 1996, Volume: 23, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Bone Density; Carcinoma; Case-Control Studies; Female; Hip; Humans;

1996
Endogenously labeled thyroid hormones (131I-T3/T4) in sera of patients with differentiated thyroid carcinoma.
    Thyroid : official journal of the American Thyroid Association, 1996, Volume: 6, Issue:3

    Topics: Adult; Carcinoma; Chromatography; Female; Humans; Iodine Radioisotopes; Male; Radionuclide Imaging;

1996
Prevention of thyroid neoplasm recurrence with Triac and levothyroxine.
    Clinical endocrinology, 1997, Volume: 46, Issue:1

    Topics: Carcinoma; Drug Therapy, Combination; Humans; Neoplasm Recurrence, Local; Thyroid Neoplasms; Thyroxi

1997
[The risk factors and bone mineral density in women on long-term levothyroxine treatment].
    Medicina clinica, 1999, Jan-30, Volume: 112, Issue:3

    Topics: Adult; Aged; Bone Density; Carcinoma; Combined Modality Therapy; Female; Humans; Linear Models; Midd

1999
Differentiated thyroid carcinoma (DTC) in the elderly: disease outcome, therapeutic approach, and long-term results in a group of 314 patients.
    Journal of endocrinological investigation, 1999, Volume: 22, Issue:10 Suppl

    Topics: Aged; Carcinoma; Combined Modality Therapy; Humans; Iodine Radioisotopes; Longitudinal Studies; Lymp

1999
Whole-body Tc-99m sestamibi scintigraphy in the follow-up of differentiated thyroid carcinoma.
    Clinical nuclear medicine, 2000, Volume: 25, Issue:6

    Topics: Adenocarcinoma, Follicular; Adult; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Female; Follo

2000
Promoting effects of xylazine on development of thyroid tumors in rats initiated with N-bis(2-hydroxypropyl)nitrosamine and the mechanism of action.
    Carcinogenesis, 2001, Volume: 22, Issue:4

    Topics: Adenoma; Animals; Body Weight; Carcinogens; Carcinoma; Dose-Response Relationship, Drug; Female; Hyp

2001
[Effects of L-thyroxine suppressive therapy on cardiac mass in patients with differentiated thyroid cancer].
    Polskie Archiwum Medycyny Wewnetrznej, 2001, Volume: 105, Issue:2

    Topics: Adult; Aged; Carcinoma; Cardiomegaly; Female; Humans; Male; Middle Aged; Thyroid Neoplasms; Thyroxin

2001
[L-thyroxine therapy in differentiated thyroid carcinoma: criteria for evaluation of TSH suppression].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2001, Volume: 54, Issue:5-6

    Topics: Adult; Carcinoma; Female; Humans; Male; Thyroid Neoplasms; Thyrotropin; Thyroxine

2001
Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:12

    Topics: Adolescent; Adult; Aged; Carcinoma; Female; Humans; Male; Middle Aged; Postoperative Period; Prognos

2001
Continuing occurrence of thyroid carcinoma after irradiation to the neck in infancy and childhood.
    The New England journal of medicine, 1975, Jan-23, Volume: 292, Issue:4

    Topics: Acne Vulgaris; Adenoids; Adolescent; Adult; Autoantibodies; Carcinoma; Chicago; Child; Child, Presch

1975
Human thyroid cyclic nucleotide phosphodiesterase. Its characterization and the effect of several hormones on the activity.
    Biochimica et biophysica acta, 1976, Jul-08, Volume: 438, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenoma; Calcium; Carcinoma; Cyclic AMP; Cyclic GMP; Enzyme Act

1976
Bacteriologic and systemic effects of intraoperative segmental bowel preparation with povidone iodine.
    Archives of surgery (Chicago, Ill. : 1960), 1979, Volume: 114, Issue:2

    Topics: Adult; Aged; Bacteria; Carcinoma; Colon; Colonic Diseases; Colonic Neoplasms; Humans; Iodine; Middle

1979
[Treatment of thyroid carcinoma].
    Revista do Hospital das Clinicas, 1978, Volume: 33, Issue:2

    Topics: Adolescent; Adult; Aged; Carcinoma; Child; Doxorubicin; Female; Follow-Up Studies; Humans; Iodine Ra

1978
Triiodothyronine-producing metastatic follicular thyroid carcinoma.
    Hormone research, 1977, Volume: 8, Issue:4

    Topics: Aged; Carcinoma; Female; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Thyroid Neoplasms; Thyro

1977
Iodoamino acid content and distribution in normal and abnormal human thyroids.
    The Journal of clinical endocrinology and metabolism, 1975, Volume: 41, Issue:3

    Topics: Adenoma; Carcinoma; Humans; Monoiodotyrosine; Thyroid Gland; Thyroid Neoplasms; Thyroiditis, Autoimm

1975
[Evaluation of reliable pituitary suppression therapy through varying thyroid hormone dosage following total thyroidectomy due to a differentiated thyroid carcinoma].
    Langenbecks Archiv fur Chirurgie, 1975, Volume: Suppl

    Topics: Carcinoma; Humans; Pituitary Gland; Thyroid Function Tests; Thyroid Neoplasms; Thyroidectomy; Thyrot

1975
Treatment of thyroid cancer in 293 patients.
    The British journal of surgery, 1976, Volume: 63, Issue:4

    Topics: Adenocarcinoma; Adult; Carcinoma; Carcinoma, Papillary; Female; Humans; Iodine Radioisotopes; Lympha

1976
[Atypical thyroid gland adenoma. Experiences during 12 years struma surgery].
    Zentralblatt fur Chirurgie, 1991, Volume: 116, Issue:16

    Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Combined Modality Therapy; Diagnosis

1991
[Radioimmunologic analysis in the differential diagnosis of cancer of the thyroid gland].
    Meditsinskaia radiologiia, 1991, Volume: 36, Issue:7

    Topics: Adenocarcinoma; Adenoma; Adult; Aged; Biomarkers, Tumor; Carcinoma; Diagnosis, Differential; Female;

1991
Circulating thyroglobulin measurements by homologous radioimmunoassay in dogs with thyroid carcinoma.
    Acta endocrinologica, 1991, Volume: 125, Issue:3

    Topics: Adenoma; Animals; Carcinoma; Dogs; Female; Flow Cytometry; Male; Ploidies; Radioimmunoassay; Thyrogl

1991
A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma.
    The Journal of clinical endocrinology and metabolism, 1991, Volume: 72, Issue:6

    Topics: Adult; Bone Density; Carcinoma; Female; Humans; Menopause; Middle Aged; Thyroid Neoplasms; Thyroxine

1991
Relationships between serum thyroid stimulating hormone levels and development of thyroid tumors in rats treated with N-bis-(2-hydroxypropyl)nitrosamine.
    Carcinogenesis, 1991, Volume: 12, Issue:5

    Topics: Adenoma; Animals; Body Weight; Carcinogens; Carcinoma; Dose-Response Relationship, Drug; Female; Mal

1991
Serum thyroid hormone changes in head and neck cancer patients treated with microwave hyperthermia on lymph node metastasis.
    Cancer, 1990, Feb-15, Volume: 65, Issue:4

    Topics: Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Human

1990
Measurement of serum thyroglobulin is of value in detecting tumour recurrence following treatment of differentiated thyroid carcinoma by lobectomy.
    The British journal of surgery, 1990, Volume: 77, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma; Female; Humans; Male; Middle

1990
[Familial nonneoplastic inappropriate thyrotropin secretion].
    Deutsche medizinische Wochenschrift (1946), 1990, May-25, Volume: 115, Issue:21

    Topics: Carcinoma; Diagnosis, Differential; Drug Therapy, Combination; Female; Goiter; Humans; Middle Aged;

1990
[Immunohistochemical study and lectin distribution of thyroid carcinoma originated from follicular epithelium].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 1990, Volume: 19, Issue:2

    Topics: Adenocarcinoma; Carcinoma; Carcinoma, Papillary; Humans; Immunohistochemistry; Lectins; Thyroglobuli

1990
Phenolic and tyrosyl ring iodothyronine deiodination by the Caco-2 human colon carcinoma cell line.
    Metabolism: clinical and experimental, 1989, Volume: 38, Issue:12

    Topics: Carcinoma; Cell Differentiation; Colonic Neoplasms; Humans; Intestinal Absorption; Iodine; Kinetics;

1989
Promoting effect of 2,4-diaminoanisole sulfate on rat thyroid carcinogenesis.
    Cancer letters, 1989, Volume: 45, Issue:2

    Topics: Adenoma; Animals; Body Weight; Carcinogens; Carcinoma; Cocarcinogenesis; Hair Dyes; Hair Preparation

1989
Imaging of metastatic medullary carcinoma of the thyroid with 131I-meta-iodobenzyl guanidine.
    Nuclear medicine communications, 1986, Volume: 7, Issue:4

    Topics: 3-Iodobenzylguanidine; Adult; Calcitonin; Carcinoma; Epinephrine; Female; Humans; Iodine Radioisotop

1986
[Postoperative surveillance of differentiated thyroid epithelioma. Contribution of the ultrasensitive determination of TSH].
    Presse medicale (Paris, France : 1983), 1987, Oct-31, Volume: 16, Issue:36

    Topics: Adolescent; Adult; Aged; Carcinoma; Female; Follow-Up Studies; Humans; Hyperthyroidism; Male; Middle

1987
[Therapeutic strategy in thyroid carcinoma].
    La Clinica terapeutica, 1987, Jun-30, Volume: 121, Issue:6

    Topics: Adenoma; Adolescent; Adult; Carcinoma; Carcinoma, Papillary; Child; Female; Follow-Up Studies; Human

1987
Serial serum calcitonin concentrations to evaluate response to therapy of patients with medullary thyroid carcinoma.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988, Volume: 7, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcitonin; Carcinoma; Cisplatin; Combi

1988
Early effects of cranial irradiation on hypothalamic-pituitary function.
    The Journal of clinical endocrinology and metabolism, 1987, Volume: 64, Issue:3

    Topics: Adult; Carcinoma; Estradiol; Female; Follow-Up Studies; Humans; Hydrocortisone; Hyperprolactinemia;

1987
[Biochemical and microscopic (optic and electron) comparative study of normal and tumoral thyroid tissues in man].
    Bulletin du cancer, 1985, Volume: 72, Issue:1

    Topics: Adenoma; Adult; Aged; Carcinoma; Carcinoma, Papillary; Diagnosis, Differential; Humans; Iodine; Midd

1985
[Distribution kinetics and metabolism of triiodothyronine and thyroxine in the organs and tissues of mice with transplanted Lewis carcinoma].
    Eksperimental'naia onkologiia, 1985, Volume: 7, Issue:2

    Topics: Animals; Carcinoma; Female; Kinetics; Lung Neoplasms; Mice; Mice, Inbred Strains; Neoplasm Transplan

1985
How to deal with undetectable and low measurable serum thyroglobulin levels in the follow-up of patients with differentiated thyroid carcinoma?
    Acta endocrinologica, 1985, Volume: 110, Issue:4

    Topics: Adult; Aged; Carcinoma; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Iodine Radiois

1985
[The effect of hormones and actinomycin on tumor cell multiplication in in vitro experiments].
    Voprosy onkologii, 1971, Volume: 17, Issue:4

    Topics: Antibiotics, Antineoplastic; Carcinoma; Dactinomycin; Female; Flavonoids; In Vitro Techniques; Insul

1971
[Triosorb, tetrasorb and T3 values as indicators of thyroid function].
    Horumon to rinsho. Clinical endocrinology, 1971, Volume: 19, Issue:5

    Topics: Carcinoma; Female; Goiter; Humans; Hyperthyroidism; Hypothyroidism; Male; Pregnancy; Thyroid Functio

1971
The Eaton-Lambert syndrome and autoimmune disorders.
    The American journal of medicine, 1972, Volume: 53, Issue:3

    Topics: Adult; Anemia, Pernicious; Autoimmune Diseases; Bronchial Neoplasms; Carcinoma; Electrodiagnosis; Hu

1972
Thyroxine transport and turnover in major nonthyroidal illness.
    The Journal of clinical endocrinology and metabolism, 1968, Volume: 28, Issue:7

    Topics: Adenocarcinoma; Adult; Aged; Biological Transport; Blood Proteins; Carcinoma; Carcinoma, Bronchogeni

1968
Bioassay of calcitonin by determinations of blood calcium-45 levels in rats and mice.
    Acta endocrinologica, 1973, Volume: 73, Issue:1

    Topics: Adrenocorticotropic Hormone; Animals; Biological Assay; Calcitonin; Calcium; Calcium Isotopes; Calci

1973
Thyroid proteins and hormone synthesis in human thyroid cancer.
    Acta endocrinologica, 1974, Volume: 76, Issue:4

    Topics: Adenocarcinoma; Carbon Radioisotopes; Carcinoma; Carcinoma, Papillary; Chromatography, Paper; Diiodo

1974
[Interaction of the cells of some lines obtained from tumorous and embryonic tissues].
    Voprosy onkologii, 1974, Volume: 20, Issue:3

    Topics: Animals; Carcinoma; Cell Division; Cell Line; Cells, Cultured; Colchicine; Culture Media; Cytologica

1974
On certain aspects of thyrotoxicosis and thyroid carcinoma.
    Transactions of the Medical Society of London, 1973, Volume: 89

    Topics: Adolescent; Adult; Age Factors; Aged; Carcinoma; Child; Child, Preschool; Female; History, 18th Cent

1973
Clinical research in thyroid surgery.
    Annals of the Royal College of Surgeons of England, 1972, Volume: 50, Issue:2

    Topics: Adenocarcinoma; Adult; Age Factors; Aged; Calcium; Carcinoma; Carcinoma, Papillary; Edetic Acid; Goi

1972
Thyrotropin releasing hormone (TRH) studies in patients with thyroid cancer.
    The Journal of clinical endocrinology and metabolism, 1972, Volume: 35, Issue:3

    Topics: Adenocarcinoma; Aged; Carcinoma; Female; Half-Life; Humans; Injections, Intravenous; Iodine; Iodine

1972
Iodinated thyrolipids: their possible role in homonogenesis.
    Acta endocrinologica, 1973, Volume: 74, Issue:3

    Topics: Animals; Carcinoma; Cystadenoma; Goiter, Nodular; Graves Disease; Humans; In Vitro Techniques; Iodin

1973
Proceedings: Thyroid suppression.
    Archives of surgery (Chicago, Ill. : 1960), 1974, Volume: 108, Issue:4

    Topics: Adenocarcinoma; Adult; Carcinoma; Carcinoma, Papillary; Diagnosis, Differential; Female; Humans; Iod

1974
Familial goitre with absence of thyroglobulin and synthesis of thyroid hormones from thyroidal albumin.
    The Journal of endocrinology, 1974, Volume: 60, Issue:3

    Topics: Adolescent; Albumins; Carcinoma; Centrifugation, Density Gradient; Child; Chromatography; Chromatogr

1974
[Therapy of malignant tumors of the thyroid gland].
    Schweizerische medizinische Wochenschrift, 1966, Feb-26, Volume: 96, Issue:8

    Topics: Adenocarcinoma; Carcinoma; Humans; Iodine Isotopes; Radiotherapy, High-Energy; Sarcoma; Thyroid Neop

1966
Diagnosis of thyroid disorders using radio-active iodine isotopes. Experiences and results 1962-1971.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1972, Jan-29, Volume: 46, Issue:5

    Topics: Adenoma; Carcinoma; Female; Goiter; Humans; Hyperthyroidism; Hypothyroidism; Iodine Radioisotopes; M

1972
Radioimmunoassay for human thyrotrophin. Clinical value in patients with normal and abnormal thyroid function.
    Annals of internal medicine, 1971, Volume: 74, Issue:4

    Topics: Adolescent; Adult; Age Factors; Aged; Basal Metabolism; Blood Proteins; Carcinoma; Child; Child, Pre

1971
Carcinoma of the thyroid.
    Guy's Hospital reports, 1969, Volume: 118, Issue:3

    Topics: Adenocarcinoma; Adult; Carcinoma; Carcinoma, Papillary; Child; Female; Humans; Iodine Isotopes; Male

1969
[Pathology and therapy of struma maligna].
    Deutsche medizinische Wochenschrift (1946), 1970, Mar-27, Volume: 95, Issue:13

    Topics: Adolescent; Adult; Aged; Carcinoma; Child; Female; Humans; Iodine Isotopes; Male; Middle Aged; Neopl

1970
The influence of thyroactive substances on the induction of cervico-vaginal tumours in intact and castrate rats.
    British journal of cancer, 1970, Volume: 24, Issue:3

    Topics: Animals; Benz(a)Anthracenes; Body Weight; Carcinoma; Castration; Diethylstilbestrol; Drug Synergism;

1970
A review of the treatment of 222 patients with malignant tumours of the thyroid gland.
    Neoplastic disease at various sites, 1970, Volume: 6

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Bone Neoplasms; Carcinoma; Carcinoma, Papillary; Child; Fem

1970
The effect of sex and of sex and thyroid hormones on the induction of cancers in the salivary glands of rats.
    British journal of cancer, 1966, Volume: 20, Issue:4

    Topics: Animals; Benz(a)Anthracenes; Carcinoma; Castration; Diethylstilbestrol; Female; Male; Methylthiourac

1966